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 Abstract 
Soybean A5547-127 expresses the phosphinothricin-N-acetyltransferase (pat) gene from the 
soil bacterium Streptomyces viridochromogenes. The encoded PAT protein confers tolerance 
to the active herbicidal substance glufosinate-ammonium. Bioinformatics analyses of the 
inserted DNA and flanking sequences in soybean A5547-127 have not indicated a potential 
production of putative harmful proteins or polypeptides caused by the genetic modification. 
Genomic stability of the functional insert and consistent expression of the pat gene have 
been shown over several generations of soybean A5547-127. With the exception of the  
intended changes caused by the trans-genetically introduced trait, data from field trials 
performed in the USA show that soybean A5547-127 is compositionally, morphologically and 
agronomically equivalent to its conventional counterpart and other commercial soybean 
varieties. A repeated dose toxicity study with rats and a nutritional assessment trial with 
broilers have not revealed adverse effects of soybean A5547-127. These studies indicate that 
soybean A5547-127 is nutritionally equivalent to and as safe as conventional soybean 
varieties. The PAT protein produced in soybean A5547-127 does not show sequence 
resemblance to known toxins or IgE-dependent allergens, nor has it been reported to cause 
IgE-mediated allergic reactions. Soybean is not cultivated in Norway, and there are no cross-
compatible wild or weedy relatives of soybean in Europe.  
Based on current knowledge the VKM GMO Panel concludes that with the intended usage, 
there are no discernible safety concerns associated with soybean A5547-127 regarding 
human or animal health or to the environment in Norway.  
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 Summary 
In preparation for a legal implementation of EU-regulation 1829/2003, the Norwegian 
Scientific Committee for Food Safety (VKM) has been requested by the Norwegian 
Environment Agency (former Norwegian Directorate for Nature Management) and the 
Norwegian Food Safety Authority (NFSA) to conduct final food, feed and environmental risk 
assessments of all genetically modified organisms (GMOs) and products containing or 
consisting of GMOs that are authorised in the European Union under Directive 2001/18/EC or 
Regulation 1829/2003/EC. The request covers scope(s) relevant to the Gene Technology Act. 
The request does not cover GMOs that VKM already has conducted its final risk assessments 
on. However, the Agency and NFSA requests VKM to consider whether updates or other 
changes to earlier submitted assessments are necessary. 
The herbicide-tolerant genetically modified soybean A5547-127 (Unique Identifier ACS-
GMØØ6-4) from Bayer CropScience is approved under Regulation (EC) No 1829/2003 for 
food and feed uses, import and processing since 10 February 2012 (Application 
EFSA/GMO/NL/2008/52, Commission Decision 2012/81/EC). 
Soybean A5547-127 has previously been assessed as food and feed by the VKM GMO Panel 
commissioned by the Norwegian Food Safety Authority and the Norwegian Environment 
Agency related to the EFSAs public hearing of the application EFSA/GMO/2008/52 in 2008 
(VKM 2008).  
The food, feed and environmental risk assessment of the soybean A5547-127 is based on 
information provided by the applicant in the application EFSA/GMO/NL/2008/52, and 
scientific comments from EFSA and other member states made available on the EFSA 
website GMO Extranet. The risk assessment also considered other relevant peer-reviewed 
scientific literature.   
The VKM GMO Panel has evaluated A5547-127 with reference to its intended uses in the 
European Economic Area (EEA), and according to the principles described in the Norwegian 
Food Act, the Norwegian Gene Technology Act and regulations relating to impact assessment 
pursuant to the Gene Technology Act, Directive 2001/18/EC on the deliberate release into 
the environment of genetically modified organisms, and Regulation (EC) No 1829/2003 on 
genetically modified food and feed. The Norwegian Scientific Committee for Food Safety has 
also decided to take account of the appropriate principles described in the EFSA guidelines 
for the risk assessment of GM plants and derived food and feed (EFSA 2011a), the 
environmental risk assessment of GM plants (EFSA 2010a), selection of comparators for the 
risk assessment of GM plants (EFSA 2011b) and for the post-market environmental 
monitoring of GM plants (EFSA 2011c).  
The scientific risk assessment of soybean A5547-127 includes molecular characterisation of 
the inserted DNA and expression of novel proteins, comparative assessment of agronomic 
and phenotypic characteristics, nutritional assessments, toxicology and allergenicity, 
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unintended effects on plant fitness, potential for gene transfer, interactions between the GM 
plant, target and non-target organisms, and effects on biogeochemical processes.  
It is emphasised that the VKM mandate does not include assessments of contribution to 
sustainable development, societal utility or ethical considerations, according to the 
Norwegian Gene Technology Act and Regulations relating to impact assessment pursuant to 
the Gene Technology Act. These considerations are therefore not part of the risk assessment 
provided by the VKM Panel on Genetically Modified Organisms. Likewise, the VKM mandate 
does not include evaluations of herbicide residues in food and feed from genetically modified 
plants. 
Soybean A5547-127 is derived from the conventional soybean variety A5547, which was 
transformed using particle bombardment. Soybean A5547-127 expresses the 
phosphinothricin-N-acetyltransferase (pat) gene, from the soil bacterium Streptomyces 
viridochromogenes. The encoded PAT protein confers tolerance to the active herbicidal 
substance glufosinate-ammonium. 
Molecular characterisation 
The applicant has provided sufficient analyses to characterise the DNA inserts, number of 
inserts, integration sites and flanking sequences in the soybean genome. The results show 
that one full length functional copy of the pat gene is present in the soybean A5547-127 
genome. Similarity searches in 2007 and 2009, with databases of known toxins and allergens 
did not indicate any potential production of harmful proteins or polypeptides caused by the 
genetic modification. Southern blot and segregation analyses show that the introduced gene 
elements are stably inherited and expressed over several generations, and consistent with 
the observed phenotypic characteristics of soybean A5547-127. The VKM GMO Panel 
concludes that the molecular characterisation of soybean A5547-127 does not indicate a 
safety concern. 
Comparative assessments 
The VKM GMO Panel has considered the available literature on compositional data and found 
that except for small intermittent variations, no biologically relevant differences exist 
between soybean A5547-127 and its corresponding control A5547 in the analyses of seeds 
and various processed food and feed commodities. The data presented do not show 
unintended effects as a result of the genetic modification.  
Based on current knowledge, the VKM GMO Panel concludes that with the exception of the 
introduced trait, soybean A5547-127 is compositionally, agronomically and morphologically 
equivalent to its conventional counterpart and other conventional soybean varieties.  
Food and feed risk assessment 
A 14-day repeated dose toxicity study with rats fed PAT protein, as well as a nutritional 
assessment trial with broilers fed diets containing soybean A5547-127 did not indicate any 
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adverse effects. The PAT protein in A5547-127 does not show sequence resemblance to 
known toxins or IgE-dependent allergens, nor has it been reported to cause IgE-mediated 
allergic reactions.  
Based on current knowledge, the VKM GMO Panel concludes that soybean A5547-127 is 
nutritionally equivalent to and as safe as its conventional counterpart and other conventional 
soybean varieties. 
Environmental assessment 
Considering the intended uses of soybean A5547-127, excluding cultivation, the 
environmental risk assessment is concerned with accidental release into the environment of 
viable grains during transportation and processing, as well as indirect exposure to 
microorganisms in the gastrointestinal tract and soil, mainly via intestinal content and faeces 
from animals fed feeds containing soybean A5547-127.  
Soybean A5547-127 has no altered survival, multiplication or dissemination characteristics 
compared to conventional soybean, and there are no indications of an increased likelihood of 
spread and establishment of feral soybean plants in the case of accidental release into the 
environment of seeds from soybean A5547-127. Soybean is not cultivated in Norway, and 
there are no cross-compatible wild or weedy relatives of soybean in Europe. Plant to plant 
gene flow is therefore not considered to be an issue. Considering the intended use as food 
and feed, interactions with the biotic and abiotic environment are not considered to be an 
issue. 
Overall conclusion 
Based on current knowledge and considering the intended usage, the VKM GMO Panel 
concludes that soybean A5547-127 is as safe as its conventional counterpart and other 
commercial soybean varieties. With the exception of the introduced trait, soybean A5547-127 
is nutritionally, morphologically and agronomically equivalent to conventional soybean 
varieties.  
Likewise, the VKM GMO Panel concludes that soybean A5547-127 does not represent a 
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 Sammendrag på norsk 
Som en del av forberedelsene til implementering av EU-forordning 1829/2003 i norsk rett, er 
Vitenskapskomiteen for mattrygghet (VKM) bedt av Miljødirektoratet (tidligere Direktoratet 
for naturforvalting (DN)) og Mattilsynet om å utarbeide endelige helse- og 
miljørisikovurderinger av alle genmodifiserte organismer (GMOer) og avledete produkter som 
inneholder eller består av GMOer som er godkjent under forordning 1829/2003 eller direktiv 
2001/18, og som er godkjent for ett eller flere bruksområder som omfattes av 
genteknologiloven. Miljødirektoratet og Mattilsynet har bedt VKM om endelige 
risikovurderinger for de EU-godkjente søknader hvor VKM ikke har avgitt endelige 
risikovurderinger. I tillegg er VKM bedt om å vurdere hvorvidt det er nødvendig med 
oppdatering eller annen endring av de endelige helse- og miljørisikovurderingene som VKM 
tidligere har levert. 
Den genmodifiserte, herbicidtolerante soyalinjen A5547-127 (unik kode ACS-GMØØ6-4) fra 
Bayer CropScience ble godkjent til import, videreforedling og til bruk som mat og fôr under 
EU-forordning 1829/2003 10. februar 2012 (Kommisjonsbeslutning 2012/81/EU).  
Soyalinjen A5547-127 ble første gang vurdert av VKMs faggruppe for GMO i 2008 (VKM 
2008). Helse- og miljørisikovurderingen ble utført på oppdrag av Mattilsynet og 
Miljødirektoratet i forbindelse med EFSAs offentlige høring av søknad 
EFSA/GMO/NL/2008/52.  
Risikovurderingen av den genmodifiserte soyalinjen er basert på uavhengige vitenskapelige 
publikasjoner og dokumentasjon som er gjort tilgjengelig på EFSAs nettside EFSA GMO 
Extranet. Vurderingen er gjort i henhold til tiltenkt bruk i EU/EØS-området, og i 
overensstemmelse med miljøkravene i genteknologiloven med forskrifter, først og fremst 
forskrift om konsekvensutredning etter genteknologiloven. Videre er kravene i EU-forordning 
1829/2003/EF, utsettingsdirektiv 2001/18/EF (vedlegg 2, 3 og 3B) og veiledende notat til 
Annex II (2002/623/EF), samt prinsippene i EFSAs retningslinjer for risikovurdering av 
genmodifiserte planter og avledete næringsmidler (EFSA 2006; 2010; 2011 a,b,c) lagt til 
grunn for vurderingen.  
Den vitenskapelige vurderingen omfatter transformeringsprosess og vektorkonstruksjon, 
karakterisering og nedarving av genkonstruksjonen, komparativ analyse av ernæringsmessig 
kvalitet, mineraler, kritiske toksiner, metabolitter, antinæringsstoffer, allergener og nye 
proteiner. Videre er agronomiske egenskaper, potensiale for utilsiktede effekter på fitness, 
genoverføring, og effekter på målorganismer, ikke-målorganismer og biogeokjemiske 
prosesser vurdert. 
Det presiseres at VKMs mandat ikke omfatter vurderinger av etikk, bærekraft og 
samfunnsnytte, i henhold til kravene i den norske genteknologiloven og dens 
konsekvensutredningsforskrift. Disse aspektene blir derfor ikke vurdert av VKMs faggruppe 
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for genmodifiserte organismer. Vurderinger av mulige plantevernmiddelrester i den 
genmodifiserte planten som følge av endret sprøytemiddelbruk faller per i dag utenfor VKMs 
ansvarsområde og er derfor heller ikke vurdert.  
Soya A5547-127 har fått innsatt et pat-gen fra jordbakterien Streptomyces 
viridochromogenes. Genet koder for enzymet fosfinotricin acetyltransferase (PAT), som 
acetylerer og inaktiverer glufosinat-ammonium, virkestoffet i fosfinotricin-herbicider av typen 
Finale® og Liberty®. Fosfinotricin er et ikke-selektivt kontaktherbicid som hemmer 
glutaminsyntetase. Enzymet deltar i assimilasjonen av nitrogen og katalyserer omdanning av 
glutamat og ammonium til aminosyren glutamin. Hemming av glutaminsyntetase fører til 
akkumulasjon av ammoniakk, og til celledød i planten. De genmodifiserte soyaplantene vil 
derfor tolerere høyere doser av plantevernmidler med virkestoffet glufosinat-ammonium 
sammenlignet med konkurrerende ugras. 
Molekylær karakterisering 
Søkeren har oppgitt tilstrekkelige analysedata til å karakterisere de introduserte DNA-
innskuddene, antallet integreringer, integreringssteder, og innskuddenes flankerende DNA-
sekvenser i genomet til soya A5547-127. Resultatene viser at kun ett funksjonelt pat gen er 
integrert i genomet til soyalinjen. Homologisøk fra 2007 og 2009, med databaser over kjente 
toksiner og allergener, indikerer at genmodifiseringen ikke har ført til potensiell produksjon 
av skadelige proteiner eller polypeptider i soya A5547-127. Southern blot og segresjons -
analyser viser at det introduserte genet er stabilt nedarvet og uttrykt over flere 
generasjoner, og i samsvar med de fenotypiske egenskapene til soya A5547-127. VKMs 
faggruppe for GMO konkluderer med at den molekylære karakteriseringen ikke indikerer 
noen helserisiko ved soya A5547-127. 
Komparative analyser 
VKMs faggruppe for GMO har vurdert tilgjengelig litteratur vedrørende soya A5547-127 og 
funnet at det, med unntak av små tilfeldige variasjoner i enkeltparametere målt i bønner og 
noen prosesserte komponenter til bruk i mat og fôr, ikke foreligger biologisk relevante 
forskjeller mellom den genmodifiserte soyaen og dens kontroll. De rapporterte dataene viser 
ingen utilsiktede effekter som følge av genmodifiseringen. 
Ut i fra dagens kunnskap konkluderer VKMs faggruppe for GMO at soya A5547-127, med 
unntak av den introduserte egenskapen, er ernæringsmessig, agronomisk, og morfologisk 
vesentlig lik dens konvensjonelle motpart, samt andre konvensjonelle soyasorter.  
Helserisiko 
En 14 dagers toksisitetsstudie med rotter gitt PAT-protein i fôret, og en ernæringsstudie 
utført med broilere gitt fôr inneholdende soya A5547-127, har ikke indikert helseskadelige 
effekter. PAT-proteinet viser ingen sekvenslikhet med kjente toksiner eller IgE-bundne 
allergener, og er heller ikke rapportert å ha forårsaket IgE-medierte allergiske reaksjoner.  
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Ut i fra dagens kunnskap konkluderer VKMs faggruppe for GMO at soya A5547-127 er 
ernæringsmessig lik, og like trygg som, dens konvensjonelle motpart og andre 
konvensjonelle sorter. 
Miljørisiko 
Med bakgrunn i tiltenkt bruksområde for søknaden er miljørisikovurderingen av soyalinjen 
A5547-127 avgrenset til mulige effekter av utilsiktet spredning av spiredyktige frø i 
forbindelse med transport og prosessering, samt indirekte eksponering gjennom gjødsel fra 
husdyr fôret med genmodifisert soya. Faggruppen har ikke vurdert mulige miljøeffekter 
knyttet til dyrking av soyalinjen. Genmodifiseringen av soya A5547-127 har ikke medført 
endringer i egenskaper knyttet til overlevelse, oppformering eller spredning sammenlignet 
med konvensjonell soya, og det er ingen indikasjoner på økt sannsynlighet for spredning og 
etablering av ferale soyaplanter fra utilsiktet frøspill av soyalinjen. Soya dyrkes ikke i Norge, 
og arten har ikke viltvoksende populasjoner eller nærstående arter utenfor dyrking i Europa. 
Det er derfor ikke risiko for utkryssing med dyrkede sorter eller ville planter i Norge. 
Samlet vurdering  
Ut i fra dagens kunnskap konkluderer VKMs faggruppe for GMO at soya A5547-127, ved 
forskreven bruk, er like trygg som dens konvensjonelle motpart og andre konvensjonelle 
soyasorter. Soya A5547-127 er ernæringsmessig, morfologisk, og agronomisk ekvivalent 
med konvensjonell soya. 
Likeledes finner faggruppen, ut i fra dagens kunnskap, at den omsøkte bruken av soya 
A5547-127 ikke vil medføre noen miljørisiko i Norge.  
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 Abbreviations and explanations 
ADF Acid Detergent Fibre. The insoluble residue remaining after boiling a 
feed/food sample in acid detergent solution. It contains many insoluble 
(structural) fibre components – lignin, cellulose, silica – but also insoluble 





Plant parts obtained during normal aspiration of cereal and oil seed 
crops in the handling of the product consisting primarily of plant 
parts, including glumes and contain not more than 15 percent ash 
(dirt), The American Feed Control Officials definition 
ARMG Antibiotic resistance marker gene 
BC Backcross. Backcross breeding is extensively used to move a single 
trait of interest (e.g. disease resistance gene) from a donor line into 
the genome of a preferred or “elite” line without losing any part of 
the preferred lines existing genome. The plant with the gene of 
interest is the donor parent, while the elite line is the recurrent 
parent. BC1, BC2 etc. designates the backcross generation number. 
 
BLAST Basic Local Alignment Search Tool. Software that is used to 
compare nucleotide (BLASTn) or protein (BLASTp) sequences to 
sequence databases and calculate the statistical significance of 
matches, or to find potential translations of an unknown nucleotide 
sequence (BLASTx). BLAST can be used to understand functional 
and evolutionary relationships between sequences and help identify 
members of gene families.  
bp Basepair 
Bt Bacillus thuringiensis 
CaMV Cauliflower mosaic virus 
Codex Set by The Codex Alimentarius Commission (CAC), an 
intergovernmental body to implement the Joint FAO/WHO Food 
Standards Programme. Its principle objective is to protect the 
health of consumers and to facilitate the trade of food by setting 
international standards on foods (i.e. Codex Standards). 
CTP Chloroplast transit peptide 
DAP  Days after planting 
DNA Deoxyribonucleic acid 
DT50 Time to 50% dissipation of a protein in soil 
DT90 Time to 90% dissipation of a protein in soil 
dw Dry weight 
dwt Dry weight tissue 
EC European Commission 
EFSA European Food Safety Authority 
ELISA Enzyme-linked immunosorbent assay 
EPSP 5-enolpyruvylshikimate-3-phosphate 
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EPSPS 5-enolpyruvylshikimate-3-phosphate synthase 
ERA Environmental risk assessment 
E-score Expectation score 
EU European Union 
fa Fatty acid 
FAO Food and Agriculture Organisation 
FIFRA US EPA Federal Insecticide, Fungicide and Rodenticide Act 
Fitness Describes an individual's ability to reproduce successfully relative to 
that of other members of its population. 
fw Fresh weight 
fwt Fresh weight tissue 
GAT Glyphosate N-acetyltransferase 
GLP Good Laboratory Practice 
Glyphosate Broad-spectrum  systemic herbicide 
GM Genetically Modified 
GMO Genetically Modified Organism 
GMP Genetically Modified Plant 
H Hybrid 
ha Hectare 
ILSI International Life Sciences Institute 
IPM Integrated Pest Management 
IRM Insect Resistance Management 
Locus The position/area that a given gene occupies on a chromosome 
LOD Limit of detection 
LOQ Limit of quantification 
MALDI-TOF Matrix-Assisted Laser Desorption/Ionisation-Time Of Flight. A mass 
spectrometry method used for detection and characterisation of 
biomolecules, such as proteins, peptides, oligosaccharides and 
oligonucleotides, with molecular masses between 400 and 350,000 
Da. 
mRNA Messenger RNA 
MS Member states 
NFSA / MT  Norwegian Food Safety Authority (Mattilsynet) 
NDF Neutral detergent fibre, measure of fibre used for animal feed 
analysis. NDF measures most of the structural components in plant 
cells (i.e. lignin, hemicellulose and cellulose), but not pectin. 
Northern blot Northern blot is a technique used to study gene expression by 
detection of RNA or mRNA separated in a gel according to size.  
NTO  Non-target organism 
Near-isogenic lines  Term used in genetics/plant breeding, and defined genetic lines 
that are identical except for differences at a few specific locations 
or genetic loci. 
OECD Organisation for Economic Co-operation and Development 
ORF Open Reading Frame, in molecular genetics defined as a reading 
frame that can code for amino acids between two stop codons 
(without stop codons). 
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OSL Over season leaf 
OSR Over season root 
OSWP Over season whole plant 
pat Phosphinothricin-Acetyl-Transferase gene 
PAT Phosphinothricin-Acetyl-Transferase protein 
PCR Polymerase chain reaction, a technique to amplify DNA by copying 
it 
R0 First transformed generation, parent 
RNA Ribonucleic acid 
RP Recurrent parent 
SDS-PAGE Sodium dodecyl sulphate polyacrylamide gel electrophoresis. 
Technique to separate proteins according to their approximate size 
SAS Statistical Analysis System 
SD Standard deviation 
Southern blot Method used for transfer of electrophoresis-separated DNA 
fragments to a filter membrane and possible subsequent fragment 




Vegetative Stages Reproductive Stages 
 VE - Emergence R1 – Beginning flowering 
 VC - Cotyledon stage R2 – Full flowering 
 V1- First trifoliolate R3 – Beginning pod (pods 5 mm 
in top 4 nodes) 
 V2 – Second trifoliolate R4 – Full pod (pods 2 cm  in top 
4 nodes) 
 V3 – Third trifoliolate R5 – Beginning seed (seed  3 
mm long in top 4 nodes) 
 V(n) – nth trifoliolate R6 – Full size seed (pod 
containing a green seed that fills 
the pod capacity in top 4 nodes 
on the main stem) 
  R7 – Beginning maturity (one 
pod on the main stem has 
reached its mature pod colour) 
  R8 – Full maturity (95 % of the 
pods on the plant have reach 
their full mature colour) 
T-DNA Transfer DNA, the transferred DNA of the tumour-inducing (Ti) 
plasmid of some species of bacteria such as Agrobacterium 
tumefaciens  and A. rhizogenes, into plant's nuclear genome. The 
T-DNA is bordered by 25-base-pair repeats on each end. Transfer is 
initiated at the left border and terminated at the right border and 
requires the vir genes of the Ti plasmid. 
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TI Trait integrated 
TMDI Theoretical Maximum Daily Intake 
Transgene copy 
number 
Transgene copy number is defined as the number of exogenous 
DNA insert(s) in the genome. If the exogenous DNA fragment 
inserts only once at a single locus of the genome, it is a single copy 
transgenic event. 
U.S. EPA United States Environmental Protection Agency 
Western blot Technique used to transfer proteins separated by gel 
electrophoresis by 3-D structure or denaturated proteins by the 
length of the polypeptide to a membrane, where they might be 
identified by antibody labelling. 
WHO World Health Organisation 
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 Background  
On 3 April 2008, the European Food Safety Authority (EFSA) received from the Competent 
Authority of the Netherlands an application (Reference EFSA/GMO/NL/2008/52) for 
authorisation of the genetically modified herbicide tolerant soybean A5547-127 (Unique 
Identifier ACS-GMØØ6-4), submitted by Bayer CropScience within the framework of 
Regulation (EC) No 1829/2003.  
The scope of the application covers:  
 Food 
 GM plants for food use 
 Food containing or consisting of GM plants 
 Food produced from GM plants or containing ingredients produced from GM  
 Plants 
 Feed 
 GM plants for feed use 
 Feed containing or consisting of GM plants 
 Feed produced from GM plants 
 GM plants for environmental release 
 Import and processing (Part C of Directive 2001/18/EC) 
After receiving the application EFSA/GMO/NL/2008/52 and in accordance with Articles 
5(2)(b) and 17(2)(b) of Regulation (EC) No 1829/2003, EFSA informed the EU- and EFTA 
Member States (MS) and the European Commission and made the summary of the dossier 
publicity available on the EFSA website. EFSA initiated a formal review of the application to 
check compliance with the requirements laid down in Articles 5(3) and 17(3) of regulation 
(EC) No 1829/2003. On 18 July 2008, EFSA declared the application as valid in accordance 
with Articles 6(1) and 18(1) of Regulation (EC) No 1829/2003.  
EFSA made the valid application available to Member States and the EC and consulted 
nominated risk assessment bodies of the MS, including the Competent Authorities within the 
meaning of Directive 2001/18/EC (EC 2001), following the requirements of Articles 6(4) and 
18(4) of Regulation (EC) No 1929/2003, to request their scientific opinion. Within three 
months following the date of validity, all MS could submit via the EFSA GMO Extranet to 
EFSA comments or questions on the valid application under assessment. The VKM GMO 
Panel assessed the application in connection with the EFSA official hearing, and submitted a 
preliminary opinion in October 2008 (VKM 2008). EFSA published its scientific opinion 10 May 
2011 (EFSA 2011d), and soybean A5547-127 was approved for food and feed uses, import 
and processing 10 February 2012 (Commission Decision 2012/81/EC). 
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 Terms of reference  
The Norwegian Environment Agency (formerly the Norwegian Directorate for Nature 
Management) has the overall responsibility for processing applications for the deliberate 
release of genetically modified organisms (GMOs). This entails inter alia coordinating the 
approval process, and to make a holistic assessment and recommendation to the Ministry of 
the Environment regarding the final authorisation process in Norway. The Agency is 
responsible for assessing environmental risks upon the deliberate release of GMOs, and to 
assess the product's impact on sustainability, benefit to society and ethics under the Gene 
Technology Act. 
The Norwegian Food Safety Authority (NFSA) is responsible for assessing risks to human and 
animal health upon the deliberate release of GMOs pursuant to the Gene Technology Act and 
the Food Safety Act. In addition, NFSA administers the legislation for processed products 
derived from GMO and the impact assessment on Norwegian agriculture according to sector 
legislation. 
The Norwegian Environment Agency 
In preparation for a legal implementation of EU-regulation 1829/2003, the Norwegian 
Environment Agency, by letter dated 13 June 2012 (ref. 2008/4367/ART-BI-BRH), requests 
VKM to conduct final environmental risk assessments for all genetically modified organisms 
(GMOs) and products containing or consisting of GMOs that are authorised in the European 
Union under Directive 2001/18/EC or Regulation 1829/2003/EC. The request covers scope(s) 
relevant to the Gene Technology Act. 
The request does not cover GMOs that VKM already has conducted its final risk assessments 
on. However, the Norwegian Environment Agency requests VKM to consider whether 
updates or other changes to earlier submitted assessments are necessary. 
The basis for evaluating the applicants’ environmental risk assessments is embodied in the 
Act Relating to the Production and Use of Genetically Modified Organisms etc. (the 
Norwegian Gene Technology Act), Regulations relating to impact assessment pursuant to the 
Gene Technology Act, the Directive 2001/18/EC on the deliberate release of genetically 
modified organisms into the environment, Guidance note in Annex II of the Directive 
2001/18 (2002/623/EC) and the Regulation 1829/2003/EC. In addition, the EFSA guidance 
documents on risk assessment of genetically modified plants and food and feed from the GM 
plants (EFSA 2010a, 2011a), and OECD guidelines will be useful tools in the preparation of 
the Norwegian risk assessments. 
The risk assessments’ primary geographical focus should be Norway, and the risk 
assessments should include the potential environmental risks of the product(s) related to any 
changes in agricultural practices. The assignment covers assessment of direct environmental 
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impact of the intended use of pesticides with the GMO under Norwegian conditions, as well 
as changes to agronomy and possible long-term changes in the use of pesticides. 
The Norwegian Food Safety Authority  
In preparation for a legal implementation of EU-regulation 1829/2003, the Norwegian 
Environment Agency has requested NFSA to give final opinions on all GMOs and products 
containing or consisting of GMOs that are authorised in the European Union under Directive 
2001/18/EC or Regulation 1829/2003/EC within the Authority’s sectoral responsibility. The 
request covers scope(s) relevant to the Gene Technology Act.  
NFSA has therefore, by letter dated 13 February 2013 (ref. 2012/150202), requested VKM to 
carry out final scientific risk assessments of 39 GMOs and products containing or consisting 
of GMOs that are authorised in the European Union.  
The assignment from NFSA includes food and feed safety assessments of GMOs and their 
derivatives, including processed non-germinating products, intended for use as or in food or 
feed.  
In the case of submissions regarding genetically modified plants (GMPs) that are relevant for 
cultivation in Norway, VKM is also requested to evaluate the potential risks of GMPs to the 
Norwegian agriculture and/or environment. Depending on the intended use of the GMP(s), 
the environmental risk assessment should be related to import, transport, refinement, 
processing and cultivation. If the submission seeks to approve the GMP(s) for cultivation, 
VKM is requested to evaluate the potential environmental risks of implementing the plant(s) 
in Norwegian agriculture compared to existing varieties (e.g. consequences of new genetic 
traits, altered use of pesticides and tillage). The assignment covers both direct and 
secondary effects of altered cultivating practices.  
VKM is further requested to assess risks concerning coexistence of cultivars. The assessment 
should cover potential gene flow from the GMP(s) to conventional and organic crops as well 
as to compatible wild relatives in semi-natural or natural habitats. The potential for 
establishment of volunteer populations within the agricultural production systems should also 
be considered. VKM is also requested to evaluate relevant segregation measures to secure 
coexistence during agricultural operations up to harvesting. Post-harvest operations, 
transport and storage are not included in the assignment.  
Evaluations of suggested measures for post-market environmental monitoring provided by 
the applicant, case-specific monitoring and general surveillance, are not covered by the 
assignment from NFSA. In addition, the changes related to herbicide residues of GMPs as a 
result of the application of plant-protection products fall outside the remit of the Norwegian 
VKM panels. 
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 Assessment 
1 Introduction 
Genetically modified soybean A5547-127 (Unique Identifier ACS-GMØØ6-4) was developed to 
provide tolerance to the herbicidal active substance glufosinate-ammonium by the 
introduction of a gene coding for the phosphinothricin N-acetyltransferase enzyme (PAT) 
from the soil bacterium Streptomyces viridochromogenes.  
Glufosinate-ammonium inhibits glutamine synthetase, leading to glutamine deficiency, 
ammonia accumulation and eventually to plant death. The PAT protein catalyses the 
conversion of glufosinate-ammonium to N-acetyl glufosinate. N-acetyl glufosinate is an 
inactive form that does not bind to glutamine synthetase allowing plants to grow in the 
presence of glufosinate-ammonium. 
The genetic modification in soybean A5547-127 is intended to improve agronomic 
performance only and is not intended to influence the nutritional properties, the processing 
characteristics or the overall use of soybean as a crop. 
Soybean A5547-127 has been evaluated with reference to its intended uses in the European 
Economic Area (EEA), and according to the principles described in the Norwegian Food Act, 
the Norwegian Gene Technology Act and regulations relating to impact assessment pursuant 
to the Gene Technology Act, Directive 2001/18/EC on the deliberate release into the 
environment of genetically modified organisms, and Regulation (EC) No 1829/2003 on 
genetically modified food and feed.  
VKM has also taken into account the appropriate principles described in the EFSA guidelines 
for the risk assessment of GM plants and derived food and feed (EFSA 2011a), the 
environmental risk assessment of GM plants (EFSA 2010a), the selection of comparators for 
the risk assessment of GM plants (EFSA 2011b), and for the post-market environmental 
monitoring of GM plants (EFSA 2011c).  
The food, feed and environmental risk assessment of the genetically modified soybean 
A5547-127 is based on information provided by the applicant in the application 
EFSA/GMO/NL/2008/52, relevant peer-reviewed scientific literature, and scientific opinions 
and comments from EFSA and other member states made available on the EFSA website 
GMO Extranet.   
It is emphasised that the VKM mandate does not include assessments of contribution to 
sustainable development, societal utility and ethical considerations, according to the 
Norwegian Gene Technology Act and Regulations relating to impact assessment pursuant to 
 
VKM Report 2015: 08  21 
 
the Gene Technology Act. These considerations are therefore not part of the risk assessment 
provided by the VKM Panel on Genetically Modified Organisms.  
2 Molecular characterisation  
2.1 Information related to the genetic modification 
 Description of the methods used for the genetic modification 2.1.1
Particle bombardment was used to transform embryo shoot apices derived from the soybean 
cultivar A5547 to generate the glufosinate-ammonium tolerant event A5547-127. DNA 
fragments of the plasmid pB2/35SAcK were used in the transformation. Initial selection was 
performed by treating new plantlets with glufosinate-ammonium and transferring tolerant 
plants to a greenhouse for further assessments and development. 
 Nature and source of vector used for the transformation 2.1.2
The plasmid pB2/35SAcK (~ 4kb) is based on the vector pUC19. It contains a Right Border 
fragment (RB) from the Agrobacterium tumefaciens Ti plasmid pTiAch5 and a synthetic pat 
gene fused to the 35S-promotor (P35S) and 35S-terminator (T35S) from Cauliflower Mosaic 
Virus (CaMV) (Berghman & De Beuckeleer, 2002a).  
The plasmid backbone contains the β-lactamase (bla) gene which confers resistance to the 
antibiotic ampicillin, and the bacterial origin of replication (ori) from vector pUC19. Prior to 
transformation, plasmid pB2/35SAcK was digested with the restriction enzyme PvuI, which 
has two restriction sites within the plasmid. One of these sites lies within the coding 
sequence of the bla gene, and thereby disrupts the gene. The PvuI digestion resulted in one 
3119bp plasmid-fragment and one 957bp fragment. A plasmid map of pB2/35SAcK is shown 
in Figure 2.1.2-1, and an overview including the relative position and function of the genetic 
elements in the plasmid is given in Table 2.1.2-1. 
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Table 2.1.2-1. Genetic elements of the plasmid pB2/35SAcK (Table 3 in Technical dossier) 
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  Source of donor DNA, size and intended function of each constituent 2.1.3
fragment of the region intended for insertion 
The right border repeat, RB, is a fragment of the octopine plasmid TiAch5 and facilitates the 
incorporation of the T-DNA to the receiving genome. The modified pat gene is derived from 
the bacterium Streptomyces viridochromogenes, a gram positive sporulating soil bacterium. 
The modified pat gene encodes the enzyme phosphinothricin acetyl transferase (PAT) which 
confers tolerance to glufosinate-ammonium based herbicides by acetylating glufosinate into 
a non-phytotoxic metabolite. The 35S promoter and 35S terminator from CaMV are derived 
from the vector PDH51, and direct constitutive expression of the pat gene and termination of 
transcripts, respectively. β-lactamase (bla) is an antibiotic resistance gene used as a bacterial 
marker during cloning. Due to cleavage by the restriction enzyme PvuI in the coding 
sequence of the bla gene, it is not functional in soybean A5547-127. The genetic elements 
are summarised in Table 2.1.3-1.  





VKM Report 2015: 08  25 
 2.2 Information relating to the GM plant 
 Description of the trait(s) and characteristics introduced or modified 2.2.1
Soybean A5547-127 contains one functional copy only of the pat gene cassette, at a single 
integration site (single locus). The pat gene encodes the enzyme phosphinothricin acetyl-
transferase (PAT) which metabolises glufosinate to an inactive, acetylated derivative, thereby 
conferring tolerance to glufosinate-ammonium herbicides (Freyssinet, 2002a).  
The native bacterial pat gene has a high G:C content, which is not typical of plant genes. To 
improve expression of pat in soybean A5547-127, a synthetic version with a lower G:C 
content was therefore constructed for the development of A5547-127. This modified pat 
gene has approximately 70% DNA sequence identity with the native pat. According to the 
applicant the modification did not alter the encoded amino acid sequence of the PAT protein. 
 Information on the sequences actually inserted or deleted 2.2.2
Molecular analyses were conducted to determine the nature, number, integrity and stability 
of the DNA insert in soybean A5547-127. Genomic DNA was analysed by Southern blot to 
determine the insert number (number of integration sites of the transgene within the 
soybean genome) and copy number (number of repeats/copies of the transgene sequence 
within one integration site/locus). The DNA insert in A5547-127 has a length of 3436 bp and 
its sequence is described in its entirety in Berghman & De Beuckeleer (2002b; updated in 
2009).  
2.2.2.1  The size, insert and copy number of all detectable inserts, both complete 
and partial 
Determination of the inserted sequences in soybean A5547-127, showed the presence of one 
copy of the pat gene cassette, as well as truncated parts of the bla gene at the 5' and 3' 
ends of the insert. According to the applicant, the integration of the insert has occurred at a 
single locus only. This is supported by the inheritance patterns of soybean A5547-127, 
described in section 2.2.4.  
The Southern blot analyses were conducted on isolated genomic DNA from leaf tissues of 
soybean A5547-127 and control plants, digested with the restriction enzymes EcoRI, SphI, 
NcoI/HindIII, HindIII, BamHI, EcoRV, and DraI. Genomic DNA from the nontransgenic 
parent cultivar A5547, and A5547 + plasmid pB2/35SAcK, were used as negative and 
positive controls, respectively. Radioactive labelled pat and bla probes were used in the 
analyses (De Beuckeleer and Botterman, 1997a). Further Southern blot analyses were 
performed by the applicant in 2009 (upon request from EFSA) with additional probes in order 
to cover the entire sequence of plasmid pB2/35SAcK. The new additional probes were: 1) a 
probe between the bla and P35S sequences and 2) a probe between T35S and bla (De 
Pestel, 2009c).  
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According to the applicant the analyses show that only one copy of the pat gene is 
integrated into the plant genomic DNA, in addition to the two truncated parts of the bla 
gene, one on each side of the pat gene cassette. The two bla fragments are integrated in 
the same orientation, but reverse to the orientation of the pat gene cassette, and do not 
constitute an intact bla gene (Figure 2.2.2.1-2). A more detailed description of the results 
can be found in the Technical dossier, De Beuckeleer & Botterman (1997a), Berghman & De 
Beuckeleer (2002b), and De Pestel (2009c). 
Figure 2.2.2.1-1 shows a schematic representation of the insert in soybean A5547-127 
including restriction sites and the original probes. Figure 2.2.2.1-2 shows the organisation 
and orientation of the bla fragments. 
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Figure 2.2.2.2-1. Schematic representation of the insert sequence in soybean A5547-127, with restriction sites used in the Southern blot analyses (Figure 11 
in Technical Dossier).  
 




Figure 2.2.2.1-2. Schematic representation of the insert sequence in soybean A5547-127, showing the 
organisation of the bla sequences (Berghman & De Beuckeleer,. 2002b). 
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 2.2.2.2  The organisation of the inserted genetic material including its sequence 
data and that of the flanking 5' and 3' regions 
In the scientific review by EFSA of application EFSA-GMO-NL-2008-52, additional information 
was requested by the EFSA Molecular Characterisation Working Group on 5 December 2008. 
Updated information was submitted by the applicant on 15 April 2009.  
This update included extended 5’ flanking sequences, from 323 bp to 1049 bp. Analysis of 
the extended sequences showed that these were identical to the already known 323 bp, and 
to the extended flanking sequences determined at the pre-insertion locus (De Pestel 2009a). 
2.2.2.3  Size and function of deleted region(s) 
According to the applicant, analyses described in a study by Habex (2008) with the thermal 
asymmetric interlaced PCR method (TAIL-PCR), showed no unintended insertion or deletion 
at the integration site in soybean A5547-127.  
 Information on the expression of the inserted sequence 2.2.3
PAT protein levels have been measured in samples of leaves, stems, and roots of soybean 
A5547-127, from greenhouse trials conducted in Belgium (De Wulf and De Pestel, 2007). 
Plants were sprayed with glufosinate-ammonium herbicide (Liberty®) before sampling at 
two different growth stages V3 (three unfolded trifoliolate leaves) and V8 (eight unfolded 
trifoliolate leaves). Samples of the unsprayed A5547 parental line were also collected at 
these two stages. PAT protein was quantified by ELISA.  
The average levels of PAT protein in the three tissues were on a fresh weight (fw) basis: 
18.40 μg/g (V3) and 26.22 μg/g (V8) in leaf, 39.18 μg/g (V3) and 13.85 μg/g (V8) in stem, 
and 8.16 μg/g (V3) and 3.60 μg/g (V8) in root. The results show a significant difference in 
PAT levels between the different plant tissues, as shown in Table 2.2.3-1.  
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Table 2.2.3-1. Summary of PAT protein levels in leaves, stems, and roots of soybean A5547-127 
(Table 10 in Technical dossier) 
 
PAT levels have also been measured in grain samples of Soybean A5547-127 grown in field 
trials in USA in 1999. Soybean A5547-127 and the non-GM counterpart A5547 (negative 
control) were planted in a total of nine plots: three plots of A5547, and six plots of soybean 
A5547-127. Three out of the six plots of A5547-127 were sprayed twice with Liberty ® - 
herbicide, at a dose of 392 g of active ingredient per hectare (ai/ha) (Shillito, 2003). The 
levels of PAT protein in grain were 17.5 and 20.2 µg/g fw for sprayed and unsprayed 
soybean A5547-127, respectively. In hulls the corresponding levels were 9.5 and 11.4 µg/g. 
PAT protein was also detected in toasted and untoasted defatted meal and soybean isolate 
at 0.069, 0.013 and 0.081 µg/g, respectively from sprayed soybean A5547-127, and 0.105, 
0.035 and 0.041 µg/g from unsprayed soybean A5547-127. No PAT protein (<4 ng/g) was 
detected in crude lecithin, refined oil, and refined bleached and deodorised oil. The PAT 
protein constitutes 0.0048% - 0.0056% of the crude protein in soybean grain, and 0.0037%- 
0.0048 % in hulls. To determine potential expression of the bla sequences in soybean 
A5547-127, the applicant has performed a Northern Blot analysis. Plant RNA was extracted 
from leaf, root and stem tissues, separated according to size and transferred to a 
membrane. The membrane was probed with radioactive labeled anti-sense bla RNA and 
measured by autoradiography. In vitro synthesised sense bla RNA served as the positive 
reference substance. The analysis detected no bla expression in the tested plant tissues (De 
Beuckeleer & Botterman, 1997b). 
2.2.3.1  Part of the plant where the insert is expressed 
Production of the PAT protein is expected to occur throughout the plant since the 35S 
promoter (P35S) from the CaMV is considered to drive constitutive expression. However, 
there is some natural variation in promoter activity between cell types, supported from the 
protein levels reported (see 2.2.3 and Table 2.2.3-1). 
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2.2.3.2  Expression of potential fusion proteins and analyses of open reading 
frames 
According to the applicant, three new junctions were created during the transformation of 
soybean A5547-127, two located at the flanking genomic host DNA, and one inside the 
insert. Analyses of these junction regions identified and characterised eight newly created 
open reading frames (ORFs 1-8) in 2007 (Vandermarliere and De Pestel, 2007). These 
analyses showed a theoretical possibility that ORF-5 could lead to the production of a newly 
created chimeric protein since it apparently has all the regulatory elements necessary to 
initiate transcription and translation. The other ORFs do not have all the regulatory elements, 
required for initiating transcription, and were therefore considered by the applicant as highly 
unlikely to produce any proteins or polypeptides. The putative ORF - translated amino acid 
sequences were compared with sequences of known toxins and allergens in the Uniprot-
Swissprot, Uniprot-TrEMBL, PIR, DAD, NRL-3D, GenPept and Allergen databases, by using 
BLASTP or FindPatterns algorithms (Capt, 2007a). According to the applicant none of the 
eight sequences presented any significant sequence identity with known toxins or allergens. 
However, the ORF-7 sequence showed significant homologies to known antibiotic resistance 
protein fragments. The observed similarities were with beta-lactamase or beta-lactamase 
precursors from various origins. Beta-lactamase is the enzyme coded by the bla gene as 
previously described. The ORF-7 sequence showed significant homology with the 5’ 
sequences of the bla fragment. 
Upon request by the Molecular Characterisation Working Group in EFSA, the applicant 
provided an updated bioinformatics analysis on ORFs, their potential expression, and new 
homology searches with databases over known toxins and allergens in 2009. In this analysis, 
the ORFs were defined as regions between start and stop and between two stop codons with 
a minimum size of three amino acids, not limiting their length, spanning the three junction 
regions formed in soybean A5547-127 (De Pestel, 2009b). The new analyses covered a total 
of 23 ORFs (Figure 1, Appendix I). The deduced amino acid sequences of these ORFs were 
compared to sequences of known toxins and allergens contained in the Uniprot-Swissprot, 
Uniprot-TrEMBL, DAD, PDB, GenPept and Allergen databases, by using BLASTP or 
FindPatterns algorithms (Capt, 2009).   
According to the applicant, the results show that the potential of producing novel chimeric 
proteins from the newly created ORFs is very low. None of the ORFs’ amino acid sequences 
showed similarity to known toxins or allergens in the tested databases.  
 Genetic stability of the insert and phenotypic stability of the GM 2.2.4
plant 
The applicant has conducted Southern blot and segregation analyses over different 
generations to assess the genetic and phenotypic stability of soybean A5547-127. 
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2.2.4.1  Genetic stability of the insert in soybean A5547-127 
In a study by De Beuckeleer (1998), Southern blot analysis was used on DNA extracts from 
leaf samples of three successive generations (R3, R4 and R5) of soybean derived from 
A5547-127. Genomic DNA from non-transgenic soybean A5547, and plasmid pB2/35SAcK 
were used as controls. The DNA samples were subjected to digestion with HindIII and NcoI, 
both enzymes having one restriction site within the transforming plasmid. The pat cassette 
sequence (EcoRI fragment of 1329 bp of plasmid pB2/35SAcK) was used as probe in the 
analysis. The probe hybridised with the plasmid and upstream plant DNA sequences when 
the samples were digested with HindIII, and with plasmid and downstream plant DNA 
sequences when digested with NcoI. The results of the analysis showed no differences in 
banding patterns between the samples, indicating genetic stability of the insert over at least 
three generations of soybean A5547-127. 
2.2.4.2  Phenotypic stability of the glufosinate-ammonium tolerant trait in 
A5547-127 
The applicant has assessed the phenotypic stability of soybeans derived from event A5547-
127 by evaluating the inheritance patterns of glufosinate-ammonium tolerance through 
successive generations (Van Wert,. 1998). The original (R0) hemizygous (pat/-) transformant 
plant was first self-pollinated to produce R1 progeny seeds, consisting of homozygous 
(pat/pat), heterozygous (pat/-) and homozygous non-transgenic (-/-) seeds (expected ratio 
of 1:2:1, respectively). The R1 progeny seeds were subsequently planted and the R2 plants 
sprayed with glufosinate-ammonium. 
R2 seeds from the R1 plants tolerant to glufosinate-ammonium (pat/pat or pat/- plants) 
were retained and planted in a plant to row fashion (i.e. rows were planted with seeds taken 
from only one plant).  
If the pat gene was inherited as a single dominant gene, it would be expected that the R2 
plants in 1/3 of the rows would be fully tolerant to glufosinate-ammonium (pat/pat) and 2/3 
of the rows would consist of both fully tolerant and partially tolerant plants, as well as plants 
sensitive to glufosinate-ammonium (pat/pat, pat/-, and -/-). The results show that 10 rows 
were fully tolerant and 21 rows were partially tolerant to glufosinate-ammonium (Table 1, 
Appendix I). Of the plants in the partially tolerant rows, it would be expected that ¾ of the 
plants would be tolerant to glufosinate ammonium and ¼ would not. Progeny (R3) from 
most rows segregated in a 3:1 fashion with respect to glufosinate- ammonium tolerance. 
According to the applicant these results were somewhat affected by an infestation with white 
grubs (Phyllophaga spp.) as indicated by deviations in rows 9, 14, 25, 29 (Table 1, Appendix 
I). However, the overall results show an expected distribution of glufosinate-ammonium 
tolerant to sensitive plants according to Mendelian laws of inheritance, consistent with a 
single dominant pat locus. 
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 2.3 Conclusion 
The applicant has provided sufficient analyses to characterise the DNA inserts, number of 
inserts, integration sites and flanking sequences in the soybean genome. The results show 
that one full length functional copy of the pat gene is present in the soybean A5547-127 
genome. Similarity searches in 2007 and 2009, with databases of known toxins and allergens 
did not indicate any potential production of harmful proteins or polypeptides caused by the 
genetic modification. Southern blot and segregation analyses show that the introduced gene 
elements are stably inherited and expressed over several generations, and consistent with 
the observed phenotypic characteristics of soybean A5547-127. The VKM GMO Panel 
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 3 Comparative assessments 
3.1 Production of material for comparative assessment 
For compositional studies, A5547-127 soybean was compared to the commercial non-
transgenic parental variety A5547 (conventional counterpart; control), which is grown in the 
US because of its desirable agronomic performance. Compositional and nutritional analyses 
were performed on the raw agricultural commodity soybean seed. The seeds were grown at 
16 field trial sites in the USA in the years 1999, 2000 and 2006 (Table AII-1). 
The plants in this study were grown in a randomised block design. The growth conditions 
were typical of production practices for cultivars of an intermediate plant type (belongs to 
maturity group V), which are well suited for growing in the geographic area generally 
encompassing the Mid-southern growing regions of the United States (North Carolina, 
Florida, Georgia, Mississippi and Arkansas). The A5547 background combines high yield, 
good standability, excellent emergence and tolerance to some of the leaf and stem diseases. 
The transgenic A5547-127 was in addition to A5547, also compared to unrelated non-
transgenic soybeans for which information was available in the literature (Table AII-3). 
At each test site transgenic soybean A5547-127 was grown at six plots and non-transgenic 
soybean A5547 was grown at three plots. Three of the transgenic A5547-127 plots were 
sprayed two times with glufosinate ammonium herbicide (Liberty Link), while the other three 
plots were untreated. The fields were sprayed twice at the equivalent of 500 g of active 
ingredient (ai) per Ha.  
The soybean seeds that were processed to various soybean products were grown at site 402 
in Arkansas, USA in year 2006 (Technical dossier, Öberdoerfer, 2008). Material from two test 
plots established in this field trial was used for the processing experiment. One plot was 
planted with the non-transgenic counterpart soybean variety A5547. On the other plot the 
transgenic soybean event A5547-127 was grown and sprayed two times with glufosinate 
ammonium herbicide. The two soybean seed samples were processed into hulls, untoasted 
meal, toasted meal, protein isolate, crude oil, refined oil, refined, bleached and deodorized 
oil (food grade oil) and crude lecithin. The processed samples were analyzed for some 
nutrients (Table AII-2).  Soybean protein concentrate, used extensively in formulated feeds 
for Norwegian salmonid aquaculture, was apparently not analysed. 
Statistical analysis 
All statistical analysis was performed with SAS version 8.2 (WINDOWS XP). In total 143 
soybean seed samples from 16 sites were analysed for 84 components.  
Analysis of differences was done by descriptive statistics: For each component mean values, 
standard deviations, minimum and maximum were calculated by site, by year and overall. A 
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by-site (or site by site) analysis of differences was performed for each component: analysis 
of variance (ANOVA) with 95% confidence level. The means have been compared with a t 
test, at 95% confidence level. 
Overall analysis: Field trials are performed at 3 comparable sites in 1999 and 2000 (sites 
201-99 and 201-00 (North Carolina), 301-99 and 302-00 (Florida) as well as sites 402-99 and 
403-00 (Arkansas) and at 3 comparable sites in 2000 and 2006 (sites 403-00 and 402-06 
(Arkansas), 404-00 and 404-06 (Arkansas) as well as sites 405-00 and 407-06 (Louisiana) 
(Table AII-1). The data from these locations were analysed separately for field trials 
performed in the two years 1999/2000 and 2000/2006 with analysis of variance (ANOVA), 
95% confidence level, and a mixed model with the factors TREAT (for treatment) and YEAR 
treated as fixed effects and SITE (for location) as a random effect omitting interaction terms. 
Based on the ANOVA model treatment, the significance of differences between A (control) 
versus B (transgenic not sprayed) and A versus C (transgenic sprayed with glufosinate) were 
estimated (Technical dossier, Rattemeyer-Matschurat, 2008a). B versus C was apparently not 
analysed. None of the studies were performed according to EFSA’s most recent guidelines 
(EFSA, 2011) however the studies were carried out prior to the publication of these 
guidelines. 
3.2 Compositional analysis 
 Field trials performed in 1999, 2000 and 2006 3.2.1
Soybean seeds were collected for compositional analysis. The following components were 
analysed, the proximate and fibre compounds, the total amino acids, the total fatty acids, 
the micro-nutrients, such as minerals and vitamins, the isoflavones, and the anti-nutrients 
raffinose, stachyose, phytic acid, trypsin inhibitors, and lectins,. Table AII-2 lists the 
components analysed in the raw agriculture commodity seeds, as well as other important 
components analysed in the processed soybean products. The compounds analysed were 
those suggested relevant according to the recommendation by OECD (OECD, 2001). 
The applicant has compared the compositional data in soybean A5547-127 and A5547 with 
standard composition data taken from the sources presented in Table AII-3.  
Proximate and fiber composition of harvested seeds 
In Table AII-4, the mean values from all sites of proximates in seeds are presented, together 
with standard composition data for soybean. All values are within the reference ranges found 
in the literature, except for moisture. The moisture content of seeds depends on the post-
harvest treatment like drying or storing, which can be carried out under varying conditions. 
To enable and facilitate the comparison of analytical results, the fresh weight values are 
always transformed into dry matter values. The by-site analysis of all proximates except 
moisture resulted in statistically significant differences (p< 0.05) between treatments for up 
to six of 16 sites. For moisture, comparing treatment A (control) versus B (transgenic not 
sprayed) indicated statistically significant differences for a total of eight of the 16 sites.  
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When A (control) versus C (transgenic sprayed with glufosinate) were compared, a total of 
seven out of 16 sites were significantly different (Table AII-5). All values were, however, 
within the range of values reported for soybeans. 
Amino acid composition of harvested seeds 
Soybean is considered a good protein source, but compared to other plant protein sources it 
contains a lower level of the essential amino acid methionine. The measured average levels 
of amino acids, including methionine, from all sites were well within the range of values 
reported in the literature (Table AII-6). The results of the by-site analysis are shown in Table 
AII-7. At maximum six of 16 sites, significant differences between sites were found (p<0.05; 
Table AII-7). However, the applicant has not evaluated/provided data regarding the 
concentration differences of essential and/or limiting amino acids between sites. 
 
Fatty acid composition of harvested seeds  
Soybean belongs to the oleic- (C18:1) and linoleic acid (C18:2) rich seed oils. Other main 
fatty acids in soybean oil are palmitic acid (C16:0), stearic acid (C18:0) and linolenic acid 
(C18:3). Both linoleic- and linolenic acids are essential fatty acids for humans and mammals. 
The mean fatty acid contents over all sites are presented together with the literature values 
in Table AII-8. The measured levels are in good compliance with the composition ranges 
reported in the literature. 
In the by-site analysis, more significant differences between treatments A versus C were 
found than between A versus B among the sites (Table AII-9). For oleic acid (C18:1), the 
majority of sites (nine of 16) in the by site analyses of A versus C resulted in statistically 
significant differences (p<0.05), in the comparision of A versus B three of 16 sites were 
significantly diffrerent. For palmitic (C16:0) and linoleic (C18:2) acids half of the sites 
differed significantly between the treatments A and C. In the comparison between the 
treatments A and B, seven of the 16 sites were significantly different for palmitic acid, while 
for linoleic acid four of 16 sites were significantly different. An overall observation is that a 
higher number of sites are significantly different when comparing control (A) with genetically 
modified and glufosinate treated soybeans (C), than when comparing control (A) with 
genetically modified soybeans not treated with glufosinate (B). 
The overall analyses including the year effects confirmed this difference for the respective 
subsets of data. The estimated differences between the oleic acid mean values for the non-
transgenic and the transgenic groups are all lower than 1.5%. Oleic acid does not belong to 
the essential, poly-unsaturated fatty acids and can be synthesised in mammals. The 
difference observed is therefore not regarded as having any biological relevance or 
nutritional impact on human or animal diet. The mean content of palmitic acid overall sites 
was for treatment A 11.4% and for treatment C 11.6% ((Table II-8). For the essential 
linoleic acid the values were 51.8% and 50.9% for treatment A and C, respectively. 
However, the applicant has not evaluated/provided data regarding the concentration 
differences of essential and/or limiting fatty acids between sites. 
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Minerals and vitamins in harvested seeds 
The overall site averages for mineral and vitamin contents are presented together with the 
literature values in table AII-10. The measured levels are in good compliance with the 
composition ranges reported in the literature. 
In Table AII-11, the by-site analysis of minerals and vitamins are presented. For a majority 
of the sites no statistical significant differences between the two treatments of A5547-127 
compared to the control A5547 were detected. However, the applicant has not 
evaluated/provided data regarding the concentration differences of essential and/or limiting 
minerals or vitamins between sites.  
 
Antinutrients in harvested seeds 
Overall mean antinutrient levels across sites for each treatment groups are given in Table 
AII-12. The two transgenic treatment groups had slightly lower raffinose mean values but 
slightly higher phytic acid and trypsin inhibitor values than the non-transgenic control group. 
For raffinose, the estimated difference between treatment means for A5547-127 and its 
nontransgenic counterpart A5547 was less than 0.1% dry matter on the basis of a 95% 
confidence interval (results not shown; Technical dossier, Öberdoerfer, 2008). These findings 
were not confirmed by the comparison between the non-transgenic control (A) and the 
transgenic seed group obtained from untreated plants (B), nor by the overall analyses 
including the year effects. The raffinose, phytic acid and trypsin inhibitor mean values for all 
three treatment groups were within the reference ranges.  
For all anti-nutrient compounds except raffinose, few significant differences were identified 
in the by-site analysis, although more were seen in A vs. C than A vs. B. For the anti-nutrient 
raffinose, the statistical evaluation resulted in findings of significant differences in the 
comparison between the A and C treatment groups at the majority of test sites (Table AII-
13). For nine out of sixteen sites, the t-tests resulted in significant differences (p<0.05) 
between treatment A and C, with slightly lower values of raffinose in the the GM A5547-127 
than in the control. However, this was not confirmed by the comparison between raffinose 
data obtained from treatment A and B seed samples. Slightly higher mean phytic acid and 
trypsin inhibitor values were observed for transgenic groups B and C. However, soybean 
seeds are soaked, heat-treated, and/or fermented before consumed by humans or animals. 
This lowers the contents of many antinutrients to levels that do not cause discomfort or alter 
nutrient digestibility. The practical importance for production animals may be more relevant, 
and should be evaluated on a case-by-case basis.   
Isoflavones in harvested seeds 
Soybeans contain a number of isoflavone compounds, reported to have both beneficial and 
adverse biological effects at higher intake levels. In the plant, they occur as glucosides, 
acetylglucosides, or malonylglucosides, but they are commonly reported as aglycones. The 
over all site average contents of isoflavones are presented together with the literature values 
in table AII-14. Whereas no statistically significant difference between soybean A5547-127 
(sprayed or non-sprayed with glufosinate-ammonium containing herbicides) and the 
conventional counterpart was found for glucosides, mean levels of the daidzein, genistein, 
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and glycitein aglycone equivalents were reduced in soybean A5547-127 compared to the 
control A5547. The measured levels are in good compliance with the composition ranges 
reported in the literature (Table AII-14). 
In Table AII-15, the by-site analysis is presented. Statistically significant differences 
(p<0.05) between treatments was observed at maximum five of 16 sites. For a majority of 
the sites, no statistical significant differences between the two treatments of A5547-127 
compared to the control A5547 were detected.  
 Processed soybean product compositions from seeds harvested in 3.2.2
the field trials from 2006  
In addition to the compositional studies on soybean seeds presented above, the applicant 
compared the composition of processed products of GM soybean A5547-127 (unsprayed and 
sprayed with glufosinate-ammonium containing herbicides) with that of the conventional 
counterpart (Technical dossier, Öberdoerfer, 2008). Products analysed were hulls, untoasted 
defatted meal, toasted defatted meal, refined bleached and deodorised oil, and soy isolate 
(Table AII-2). All soybean products were analysed for proximates except the oil and lecithin 
samples. Hulls were analysed for proximates only. Untoasted and toasted meals were 
analysed for proximates, isoflavones, anti-nutrients, amino acids and fatty acids. Protein 
isolate was analysed for proximates, anti-nutrients and fatty acids. Crude and food grade 
refined oil were both analysed for tocopherols and fatty acids (Table AII-2). 
The proximate, fibre and total amino acid contents of the meal derived from A5547-127 are 
comparable to the ones determined in the A5547 meal sample. In general, the analysed 
samples show the same values as commercial soybean meal. Only the crude fat contents fell 
short of the reported range. The results from the anti-nutrient and isoflavone analyses (see 
Tables AII-12 and AII-14) indicated no major differences except for daidzin, glycitin, genistin 
and total isoflavones and all isoflavone contents were within the ranges reported in the 
literature. 
Although some data from products processed from soybean A5547-127 and the conventional 
counterpart did not fall within the range of values reported in the literature, those literature 
data could have been obtained from products produced by processing technologies that 
differed somewhat from those used in the above-mentioned study. The composition of the 
processed products did not raise any safety concerns. 
3.3 Agronomic traits and GM phenotype 
The application EFSA/GMO/NL/2008/52, covering authorisation of soybean A5547-127 for all 
food and feed uses, include data on agronomic and morphological characteristics from field 
trials in the USA in 1996, 1997, 2006 and 2007. The field trials in the 1990´s (19+48 sites) 
were made as part of the event evaluation process, and the characteristics evaluated 
included primarily those important for varietal registration (Van Wert, 1998). A two year field 
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trial performed on 8 sites in 2006 and 2007, respectively, were conducted to demonstrate 
the morphological and agronomic equivalence of soybean A5547-127 to the corresponding 
near-isogenic cultivar A5547 (Kowite, 2007, 2008). The trials were comparable and allowed a 
by-year analysis of the obtained data. 
At each field trial site, soybean A5547-127 and the conventional counterpart (A5547) were 
planted following a randomised complete block design with three replicates per site. The 
conventional counterpart was compared with soybean A5547-127 not treated with 
glufosinate-ammonium containing herbicides and soybean A5547-127 treated two times with 
the herbicide.  
No commercially available soybean varieties were included in the field trials. According to the 
updated EFSA guidance on risk assessment of food and feed from genetically modified plants 
(EFSA 2011a), there should be at least three appropriate non-GM reference varieties of the 
crop that have a known history of safe use at each site. The test of equivalence is used to 
verify whether the agronomic, phenotypic and compositional characteristics of the GM plant 
fall within the normal range of natural variation. Such a range of natural variation is 
estimated from a set of non-GM reference varieties with a history of safe use (EFSA 2011b) 
and therefore allows comparisons of the GM plant with a similar plant produced without the 
help of genetic modification and for which there is a well-established history of safe use. 
These requirements were, however, not in place at the time of submission. 
Extensive data on qualitative and quantitative characteristics were evaluated in these field 
trials; emergence, stand count, plant vigour and health rating, days to 50% flowering 
(flowering date), flower morphology and colour, pubescence colour, pod colour, hilum colour 
and shape, canopy architecture, leaf shape, plant height, susceptibility to pests and diseases, 
pollen viability and germination, and yield. A summary of the mean values and by-site 
analysis of the morphological and agronomic data are given in Tables AII-16 and AII-17, 
respectively. Due to lack of variation, analysis of variance methods were not appropriate for 
analysing the characteristics related to plant health. 
Statistical analysis across all locations revealed no statistically significant differences in the 
quantitative traits 50% plant emergence, stand count, plant vigour and yield. There were no 
significant differences in the parameters flowering date, plant height and days to maturity 
between soybean A5547-127 and A5547 at the majority of the field trial sites. Similarly, no 
overall difference between these two soybean varieties was found in the qualitative 
characteristics flower colour, pubescence colour, pod colour, hilum colour, canopy 
architecture, leaf shape and susceptibility to pests and diseases.  
For stand count, a statistical difference between the soybean A5547-127 and its comparator 
was observed when GM soybean was sprayed with glufosinate-ammonium containing 
herbicides. The differences were detected at two of the sixteen individual field trial sites 
only. No consistent trend was observed across locations and years. For the other parameters 
observed, no effects of the herbicide regimes were revealed. 
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 3.4 Conclusion 
The VKM GMO Panel has considered the available literature on compositional data and found 
that except for small intermittent variations, no biologically significant differences exist 
between soybean A5547-127 and its corresponding control A5547 in the analysis of seeds 
and various processed food and feed commodities. Any differences observed were within the 
range of values reported for conventional soybean varietals in the literature. The few 
observed statistical differences between A5547-127 and A5547 are likely to reflect the 
natural variability of the analytes since they were within the range of values reported in the 
literature for conventional soybean varietals. The data presented do not show unintended 
effects as a result of the genetic modification.  
Based on current knowledge, the VKM GMO Panel concludes that with the exception of the 
introduced trait, soybean A5547-127 is compositionally, agronomically and morphologically 
equivalent to its conventional counterpart and other conventional soybean varieties. 
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 4 Food and feed safety assessment  
4.1 Previous evaluation by the VKM GMO Panel 
In an earlier risk assessment of soybean A5547-127 the VKM GMO Panel concluded that the 
soybean A5547-127 was nutritionally equivalent to and as safe as conventional soybean 
varieties (VKM 2008).  
4.2 Product description and intended uses 
Soybean A5547-127 was first cultivated in the USA in 1998 and Canada in 1999, and 
subsequently cultivated in Japan in 2006, Brazil in 2010, Argentina in 2011, and Uruguay in 
2012. Soybean A5547-127 was commercialised for food and/or feed use in Argentina (2011), 
Australia/New Zealand (food 2004), Brazil (2010), Canada (2000), Colombia (feed 2012), EU 
(2012), India (2014), Japan (food 2001, feed 2003), Malaysia (2014), Mexico (2003), 
Phillippines (2011), Russian Federation (food, 2008, feed, 2007), South Korea (2001) and 
Taiwan (food 2010).  
Soybean A5547-127 has been used in food and feed since 1998. According to the applicant 
the commercial experience since then has confirmed that the post-harvest production and 
processing of the genetically modified A5547-127 does not differ from the production and 
processing of the equivalent foods and feeds originating from traditional soybean. The major 
soybean commodity products are seeds, oil, meal and protein concentrates/isolates. Soybean 
protein concentrate is a commonly used feed ingredient in Norwegian salmon feeds 
(www.mattilsynet.no). Since 2008, NFSA has given four fish feed producers in Norway 
extended exemption from seeking approval for inclusion of GM products in fish feeds. The 
exemption applies to processed, non-viable feed products from 19 different GM varieties. In 
October 2014, this exemption was not extended. 
Unprocessed soybeans are not suitable for food and their use in animal feed remains limited 
because they contain anti-nutritional factors such as saponins, trypsin inhibitors and lectins 
(OECD 2012). Adequate heat processing inactivates most of the biological activity of these 
factors. The main soybean product fed to animals is the defatted/toasted soybean meal. 
However, aspirated grain fractions, forage, hay, hulls, and silage are used as feed to a 
limited extent, with forage, hay and hulls primarily used for cattle (OECD 2012). Whole 
soybeans are utilised to produce food products such as soy sprouts, baked soybeans, 
roasted soybeans, full fat soy flour and the traditional Asian soy foods (miso, soy milk, soy 
sauce, and tofu) (OECD 2012). The processing steps used in food manufacturing of soybean 
are shown in Figure 4.2-1 adapted from the Technical dossier.  
The soybean A5547-127 and all food, feed and processed products derived thereof are 
expected to replace a portion of similar products from traditionally bred/selected soybean. 
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Figure 4.2-1. Processing of soybean, adapted from Waggle and Kolar, 1997, Technical dossier 
4.3 Effects of processing 
The processing steps that are used to produce the various soy products are shown in figure 
4.2-1, above. The first step in processing most soybeans is to separate the oil, either by 
solvent extraction or by expelling. For this, the soybeans are first cracked and de-hulled, 
then heated to approximately 60 degrees, ground to flakes using rollers, and are then 
treated with solvent (e.g. hexane) to remove the oil. The flakes are toasted, cooled and 
ground. During these processes, proteins in soy are subjected to harsh conditions, such as 
thermal processing, changes in pH, reducing agents, mechanical shearing, and so on, which 
can lead to denaturation and loss of protein function. Heat stability study of soybean A5547-
127 performed by the applicant (ref. Eisdail 2002c; Rascle 2009) showed that the PAT-
protein was heat stable when incubated up to 30 minutes at 90°C , and slightly degraded 
when incubated 60 minutes at 90°C.  
4.4 Toxicological assessment of soybean A5547-127 
The potential toxicity of genetically modified soybean A5547-127 has been studied in animal 
studies by the applicant. There have been different formulations of the test material. Some 
tests have been performed with the gene product of the PAT gene, produced in another 
 
VKM Report 2015: 08  44 
 
organism (E.coli) and purified before use. Other studies have been conducted with the 
complete GM food/feed. Both formulations are considered relevant for assessing the safety 
of soybean A5547-127. 
In addition to the safety testing conducted by the applicant, a safety testing programme has 
been conducted on soybean A5547-127 within the Russian Federation, summarised in 
Tutelyan (2013). The available English transcript describes the program as compliant with 
the Russian national requirements: MY 2.3.2.2306-07 “Medico-biological safety assessment 
of genetically-engineered and modified organisms of plant origin”. The content of these 
requirements and the exact design of the respective studies have however been difficult to 
assess for the VKM GMO panel, since this information is only available in Russian. Still, the 
testing conducted in the Russian Federation is deemed valuable for the risk assessment of 
soybean A5547-127. This is due to the programme being rather extensive with several 
studies conducted and many parameters monitored. Also, the studies are of particular 
interest since these are the only studies conducted with a soy protein concentrate, a main 
ingredient in Norwegian fish feed formulations. A brief summary is presented in Appendix IV. 
Submitted data by the applicant demonstrated a low expression of the transgenic PAT 
protein in soybean A5547-127 (approx. 11 µg PAT/g dry matter (dm) in seeds, approx. 77 
ng/g in meal (dm) and 14 ng/g toasted meal (dm)). The protein was not detectable in 
soybean oil (applicant dossier) and showed no meaningful amino acid sequence homology to 
known toxic proteins (Herouet et al 2005). Also in vitro digestion studies using simulated 
gastric fluid (SGF) and simulated intestinal fluid (SIF), demonstrated that PAT is rapidly 
degraded under conditions mimicking the stomach and intestine (Esdaile 2002, 2004; 
Applicant documents). Rapid degradation of the PAT-protein was also observed in pig 
stomach fluid (pH 1.7 to pH 4.0) and bovine rennet-bag (pH 1.28 to pH 3.18) (Schultz 1993, 
Applicant document). In bovine paunch (rumen) fluid (pH 7.11) total degradation of PAT-
protein was observed after 30 min (Schultz, 1993, Applicant document). Digestion of PAT-
protein in ground leaves from transgenic zoysiagrass (Z. japonica Steud.) and in total soluble 
proteins extracted from zoysiagrass has also been confirmed in studies using SGF digestion 
assays (Sun et al 2010).  
The toxicological assessment is further based on results available from testing in mice, rats 
and broiler chickens. Studies are grouped according to their objective; acute, repeated 
dosing, reproductive function, immunotoxicity etc.  
Animal studies have utilised various formulations of soybean A5547-127, such as purified 
PAT protein, protein concentrate from soybean A5547-127 or whole GM food/feed. Protein 
concentrate is about 70% soy protein and is basically defatted soy flour without the water-
soluble carbohydrates and ethanol-soluble antinutritional factors. Isolated soy proteins are 
obtained by extracting the soluble proteins with water at pH 8-9, precipitating at pH 4.5, 
centrifugation, washing, redispersing, and drying. Concentrates and isolates are widely used 
as functional or nutritional ingredients in a wide variety of food products, mainly in baked 
foods, breakfast cereals, and in some meat products.  
 
VKM Report 2015: 08  45 
 
The formulations used are indicated under each study presentation. 
 Acute toxicity testing 4.4.1
An acute intravenous study with the PAT protein has been performed by the applicant to 
assess potential toxicity in mice (Kennel, 2003, Technical dossier). The PAT protein was 
produced in E. coli, purified (>90 %), and administered i.v. to mice in a single dose. The 
OECD TG 420 fixed dose guidance document (OECD 2001) was used as a basis for assessing 
their potential acute toxicity. The number of animals, the use of a single sex and the general 
protocol details complied with this OECD guidance document. Three groups of mice (each 5 
females) were intravenously injected with 1 or 10 mg per kg body weight with either PAT 
protein, aprotinin or melittin, respectively. All animals were observed for clinical signs daily 
for 15 days after dosing. Microscopic examination of internal organs was carried out at 
necropsy. No treatment-related adverse effects were observed in mice administered the PAT 
protein at the highest dose tested, i.e. 10 mg/kg bw.  
The results showed that mice treated i.v. with PAT protein or apoprotein at 10 mg/kg body 
weight showed no signs of systemic toxicity, whereas all mice treated i.v. with melittin at the 
same dose died within 5 minutes. 
Acute toxicity testing following i.v. application of the newly expressed proteins is of little 
additional value to the risk assessment of the repeated human and animal consumption of 
food and feed derived from GM plants and is therefore not taken into account in this risk 
assessment. EFSA now discourages the use of acute toxicity studies in risk assessments of 
GMOs (EFSA 2011). 
 Repeated dose toxicity testing 4.4.2
The potential toxicity of the PAT-protein expressed in soybean A5547-127 has been assessed 
in a repeated dose toxicity study (feeding trial) in rats (Pfister et al. 1999). 
The applicant provided a 14-day repeated dose feeding study in which groups of 5 Wistar 
rats (HanIbm:WIST) of each sex were given a low protein diet containing 0, 0.5 or 5.0% 
(w/w)  (group 1, 2 and 3, respectively) of a lyophilized powder of the PAT protein (Pfister et 
al., 1999).  Group 1 were fed standard rat diet, group 4 were fed non-GM soybean protein. 
The highest dietary inclusion resulted in a daily dose of ca. 7.6 and 7.9 g/kg body weight for 
males and females, respectively. The total protein levels in the diets for the control and low-
dose groups were adjusted with soya protein from commercial non-GM soybeans to reach a 
level comparable to that in the diet for the high-dose group. An additional group was fed a 
standard rodent diet. There were no mortalities, and no relevant influence on food 
consumption and body weight development induced by the treatments. According to the 
applicant there were no adverse effects except for statistically significant increases in blood 
cholesterol levels (males of groups 2 (0.5% PAT), 3 (5% PAT) and group 4 (without PAT)) 
and phospholipid levels (females of group 3 and males of groups 2 and 3).  
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At the end of the treatment period haematology, clinical chemistry and urine analysis were 
performed, organ weights determined, and macroscopic and histopathology examinations of 
selected organs and tissues were carried out. 
This repeated dose toxicity study in rats gave no indications of adverse effects attributable to 
the PAT protein up to the highest dose tested, which was 5% in the diet, corresponding to 
7.9 g/kg bw. 
The VKM GMO-Panel notes that this repeated dose feeding study is performed with only 14 
days of exposure contrary to the recommended 28 days. 
 Studies on Allergenicity 4.4.3
4.4.3.1  Assessment of allergenicity of the new ly expressed protein 
The applicant has assessed the allergenic potential of the PAT protein by bioinformatic 
comparison of the amino acid sequence of the PAT protein produced in A5547-127 with 
known database sequences of IgE-dependent allergens, as well as the evaluation of the 
stability of the protein in an in vitro gastric digestion model. 
The pat gene originates from Streptomyces viridochromogenes, a soil microrganism that is 
not known to be allergenic. The bioinformatic analyses were conducted to assess the 
potential for allergenicity of the PAT protein sequence (Hérouet, 2004b, applicant dossier). 
The total amino acid sequence of PAT was compared with epitopes of known IgE-dependent 
allergens. In addition search was performed of potential N-glycosylation sites with known 
consensus sequences that may be found in allergenic proteins. A search was also performed 
on all protein sequences presented in reference databases, i.e. allergen, gliadin and glutenin 
sequences database (AD4) assembled from publicly available databases (GenBank, EMBL, 
PIR, NRL3D version of RCSB PDB and SwissProt) and from current literature (Uniprot-
TrEMBL, Uniprot-SwissProt, PIR, NRL_3D, DAD and GenPept). 
The applicant has also carried out an amino acid sequence homology study of the complete 
amino acid sequence of PAT with protein sequences of known toxins and allergens in the 
databases NRL-3D, PIR, DAD, GenPept, Uniprot_TrEMBL and Uniprot-SwissProt.  
The amino acid sequence of the PAT protein was compared to all sequences in the 
databases with the FASTA sequence alignment tool. The extent of each similarity was 
evaluated by visual inspection of the alignment, the calculated percent identity and the E 
score for that alignment. Additionally, the PAT amino acid sequence was also screened 
against the allergen database with an algorithm that scans for a window of eight linearly 
contiguous amino acids. Such identities might indicate the presence of potentially cross-
reactive allergenic epitopes. The results of this bioinformatics search indicate that the PAT 
protein shares no structurally significant sequence similarity to sequences within the allergen 
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databases and no immunologically significant sequence similarity to protein associated with 
IgE-mediated allergies or to proteins associated with coeliac disease. 
European and Asian patients allergic to soybean and/or other foods do not express IgE that 
specifically bind the purified PAT protein (Chang et al., 2003; Batista et al., 2005; Kim et al., 
2006a, 2006b; Hoff et al., 2007). The purified PAT enzyme also did not result in pronounced 
change in histamine release or cytokine production in sensitised peritoneal mast cells or 
unsensitised but antisera-labelled mast cells cultivated in vitro (Chang et al., 2003). It is 
considered that these studies further confirm that the expressed PAT protein in A5547-127 is 
unlikely to be allergenic. 
4.4.3.2  Assessment of the allergenicity of the whole GM plant 
In the submitted dossier the applicant has assessed the allergenicity of the whole GM plant 
as follows: Soybean is known to cause food allergies in certain individuals (Lehrer, 1997, 
applicant dossier). Therefore, an assessment of the endogenous IgE-dependent allergens in 
A5547-127 and traditional soybean has been conducted with Radioallergosorbent Test 
(RAST). The applicant screened soybean seed extracts from A5547-127 as well as from the 
non-transgenic counterparts against a panel of sera from 16 patients sensitive to soybean 
protein (Lehrer, 1997). The purpose of the study was to qualitatively and quantitatively 
compare the endogenous allergens in A5547-127 and the traditional soybean A5547 with the 
same genetic background as A5547-127. The analysis of the protein extracts prepared from 
A5547-127 revealed that both the composition and the quantity of proteins detected by 
RAST were indistinguishable from the results produced with A5547 (the control), 
demonstrating that the production of the PAT protein in A5547-127 does not cause any 
change in the composition of the allergenic proteins endogenous to soybean.  
The Food/Feed Safety Working Group in EFSA requested additional clarification and 
information from Bayer regarding the testing of seed extracts from A5547-127 in the 
experiments described above. The response from Bayer (Bayer Cropscience Response, 2010) 
provided clinical characteristics relevant for the selection of the 16 patients whose sera were 
used for the RAST experiments, along with the results of RAST tests performed on individual 
patient’s sera in terms of specific IgE values and not as percentage of binding as presented 
by Lehrer (1997). EFSA concludes that whole-product testing on sera from soybean-allergic 
patients showed that the overall allergenicity of soybean A5547-127 is not different from that 
of commercial soybeans. 
4.4.3.3  Assessment of allergenicity of proteins derived from the GM plant 
Allergenicity of the soybean could be increased as an unintended effect of the random 
insertion of the transgene in the genome of the recipient, e.g. through qualitative or 
quantitative modifications of the expression of endogenous proteins. However, given that no 
biologically relevant agronomic or compositional changes (with the exception of the 
introduced traits; see 3.2 and 3.3) and no reported difference in allergenic potential of the 
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whole plant (see 4.4.3.2) have been identified, no increased IgE-mediated allergenicity is 
anticipated for soybean A5547-127.  
 Assessment of Adjuvanticity 4.4.4
According to the EFSA Scientific Opinion on the assessment of allergenicity of GM plants and 
microorganisms and derived food and feed from GM plants (EFSA 2010c), adjuvants are 
substances that, when co-administered with an antigen increases the immune response to 
that antigen and therefore might increase the risk of allergic reactions. Adjuvanticity has not 
been routinely considered in the assessment of allergenicity of GMOs. 
In cases when known functional aspects of the newly expressed protein or structural 
similarity to known strong adjuvants may suggest adjuvant activity, the possible role of these 
proteins as adjuvants should be considered. As for allergens, interactions with other 
constituents of the food matrix and/or processing may alter the structure and bioavailability 
of an adjuvant and thus modify its biological activity.  
“Bystander sensitisation” can occur when an adjuvant in food, or an immune response 
against a food antigen, results in an increased permeability of the intestinal epithelium for 
other components in food. Previously it was assumed that the epithelial cells of the intestine 
were permanently held together tightly by the so-called tight junctions. More recent 
knowledge shows that these complex protein structures are dynamic and can become less 
tightly joined, i.e. more “leaky”, by different stimuli. 
Both in vitro and in vivo experiments have demonstrated that when an IgG response, which 
can result in a complement activation (among other reactions), is not balanced by an IgA 
response, the epithelial barrier can become leaky and unwanted proteins are able to enter 
the body (bystander-penetration) and lead to allergic sensitisation (Brandtzaeg & Tolo, 1977; 
Lim & Rowley, 1982).  
The PAT-protein has not been reported to have adjuvant properties. 
4.5 Nutritional assessment of GM food and feed 
Compositional analyses of soybean A5547-127 indicate nutritional equivalence to the non-GM 
control soybean with comparable genetic background and to the published range of values in 
the literature (see 3.2). The nutritional equivalence between soybean and non-GM control 
soybean has been further shown by the results from feeding studies with broiler chickens 
(see chapter 4.5.2). 
According to the updated version of the EFSA guidance for risk assessment of food and feed 
from genetically modified plants (EFSA, 2011a), the experimental design should always 
include the following test materials: the GM plant exposed to the intended herbicide, the 
non-GM comparator treated with conventional herbicide management regimes, and the GM 
 
VKM Report 2015: 08  49 
 
plant treated with the conventional herbicide management regimes. The broiler chicken 
study provided by the applicant is not in accordance with the suggested experimental design 
in the last EFSA guidance document on risk assessment (EFSA, 2011a). The Norwegian GMO 
Panel agrees on the importance of including GM plants treated both with and without the 
intended herbicide in comparative analysis (composition, agronomic traits, food and feed 
safety assessments), but recognises that the applicant submitted the application prior to the 
last guidance document from EFSA. 
 Intake information/exposure assessment 4.5.1
The human soybean oil consumption in Europe was calculated at 6.3-7.0 g/person/day, 
based on FAO Statistics from 1997 to 2001. Assuming that 54% of the soybean oil was 
derived from soybean A5547-127, the estimated average exposure of the European 
consumer to products of soybean A5547-127 would be approximately 3.4-3.7 g/person/ day 
(Technical dossier). 
In Table 4.5.1-1 the mean intake of soy protein/day for an adult person eating either a 
vegan menu or a milk free diet are presented (Engeset & Lillegaard, 2014, unpublished 
results). The calculations were based on week menus, for the vegan menu a person who has 
previously eaten meat and is looking for meat substitutes like soy burgers and sausages 
were envisioned. In the milk free diet, a 7 day week menu where milk products were 
replaced with soy products was composed. Both menus are included in appendix III. 
Table 4.5.1-1.  Mean intake of soy products and soy protein for adult persons with milk allergy and 
vegans with high preference for soy products. 




Milk allergy 9.7 538 19 
Vegan 10.1 865 35 
Average estimated energy requirement for children in different age groups, based on The 
Nordic Nutrition Recommendations (NNR), was used to adjust the numbers in table 4.5.1-1 
according to age to give an estimate of how much soy protein children may consume if on 
the given diets (Table 4.5.1-2). We assumed that milk in coffee/tea in the menus is 
consumed as milk by the children. 
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Table 4.5.1-2. Estimated intake of soy products and soy protein for children in different age groups, 
with milk allergy and vegans, and with high preference for soy products. 
1 Based on Nordic Nutrition Recommendations 2012 
2 Boys 10-13 years and girls 14-17 years will have approximately the same consumption as adults; estimated energy 
requirement of 9,3 and 9,8 respectively. 
Around 90% of the soybean defatted protein meal supply worldwide goes to animal feed, 
while there is limited use of soybean oil in feed. The applicant calculated, based on data 
from 2006, that the maximum inclusion levels (% of the diet) of soybean A5547-127 meal in 
the EU would be 21% for broiler chickens, 18% for pigs and 12% for dairy cattle (Technical 
dossier). 
In Norway, almost 1.5 mill tons of fish feed was produced in 2012 and soybean protein 
concentrate (SPC) is one important protein source in salmon feeds (Directorate of Fisheries, 
Biomass statistics 2013). The average inclusion level of SPC in feed for Atlantic salmon is 
25%, total SPC used for fish feed production in 2013 was calculated to be approximately 375 
000 tons (Annual Sustainability report, Skretting, 2013).  
Assuming that 100% of the SPC was derived from soybean A5547-127, the estimated 
average exposure of Atlantic salmon (post smolt, 200 g) to products of soybean A5547-127 
would be approximately 2 g/fish/day (assuming 3% growth per day and feed conversion 
ratio of 1).  
Norwegian surveillance data show that imported SPC intended for feed production only 
contains trace amounts of GMO (e.g. below 0.9%) (Spilsberg et al., 2014). The DNA specific 







Milk allergy    
2-5 year 5.3 294 10 
6-9 year 6.9 383 14 
10-13 year (girls)2 8.6 477 17 
14-17 year (boys) 2 11.8 655 23 
Vegan    
2-5 year 5.3 454 18 
6-9 year 6.9 591 24 
10-13 year (girls) 2 8,6 737 30 
14-17 year (boys) 2 11.8 1011 41 
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targets that are included in the GMO methodology are 35S promoter (p35S), Agrobacterium 
nopalin synthase terminator (tNOS), ctp2-cp4epsps, the bar gene from Streptomyces 
hygroscopicus and the pat gene from Streptomyces viridichromogenes. 
 Nutritional assessment of feed derived from the GM plant 4.5.2
4.5.2.1  Applicant’s data for nutritional assessment 
Broiler feeding study  
The applicant provided a 42-day broiler (Commercial broilers species not given) feeding 
study using a non-defined commercial strain of broilers and two types of diets (Leeson, 
1998). The rapidly growing broiler is considered to be sensitive to changes in nutrient quality 
in diets, and therefore is often used as a model to assess the wholesomeness of feed.  
The study was done to compare the wholesomeness of transgenic soybean line A5547-127 
compared to the non-transformed parental soybean lines when fed to rapidly growing 
broilers. Each treatment consisted of 120 female broilers (6 replicates of 20 birds; replicates 
in a randomised complete block design). One group of broilers received diets with seeds of 
heat-treated soybean A5547-127, another group received diets with heat-treated seeds of 
the conventional counterpart. The starter diets (day 1- 17) contained 18.24%, the grower 
diets (day 17-31) 14.94% and the finisher diets (day 31-42) 11.69% soybean meal. The 
crude protein content during the study varied from 22.0% during the starter period, to 
20.5% during the grower period, and 19.1% during the finisher period. To achieve this 
protein concentration, the diet also contained conventional corn and barley. 
There was no statistically significant effect (calculated by a T-test) of the test diet containing 
soybean A5547-127 on body weight (42-day final weight: 2132 g and 2144 g for broilers 
receiving the conventional counterpart and A5547-127, respectively), body weight gain, feed 
intake, feed intake/body weight gain or percent mortality. After 42 days, 8 birds were 
randomly selected from each pen (altogether 48 broilers per treatment) and slaughtered. 
Birds fed diets containing soybean A5547-127 showed no biologically relevant differences in 
carcass characteristics (carcass weight, abdominal fat pad weight, deboned breast meat 
weight, abdominal fat pad weight/carcass weight, and deboned breast meat yield/carcass 
weight) compared with chickens receiving diets containing seeds of the conventional 
counterpart (A5547). 
These data indicate that soybean line A5547-127 is equivalent to conventional soybean lines 
in terms of their ability to support the rapid growth of broilers and confirm the results of the 
compositional analyses. 
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 4.6 Conclusion 
A 14-day repeated dose toxicity study with rats fed PAT protein, as well as a nutritional 
assessment trial with broilers fed diets containing soybean A5547-127 did not indicate any 
adverse effects. The PAT protein in A5547-127 does not show sequence resemblance to 
known toxins or IgE-dependent allergens, nor has it been reported to cause IgE-mediated 
allergic reactions.  
Based on current knowledge, the VKM GMO Panel concludes that soybean A5547-127 is 
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 5 Environmental risk assessment 
Considering the scope of the application EFSA/GMO/NL/2008/52, the environmental risk 
assessment is concerned with the accidental release into the environment of viable soybean 
A5547-127 seeds during transport and/or processing, and with indirect exposure to 
microorganisms in the gastrointestinal tract and soil/water, mainly via ingestion by animals, 
their intestinal contents and faeces . 
5.1 Unintended effects on plant fitness due to the genetic 
modification 
Cultivated soybean, Glycine max (L.) Merr., is a member of the genus Glycine and belongs to 
the Fabaceae (Leguminosae) family. Soybean is an annual, subtropical plant, native to 
eastern Asia (OECD, 2000). The crop is however grown over a wide range of ecological 
zones, ranging from the tropics to the temperate zones (Acquaah, 2012). The major 
worldwide soybean producers are China, the United States, Brazil and Argentina (FAOSTAT, 
2013). In Europe, soybean is mainly cultivated in Ukraine, the Russian Federation, Italy, 
France and Romania. There is no cultivation of soybean in Norway.  
Despite accidental seed dispersal and extensive cultivation in many countries, seed-mediated 
establishment and survival of soybean outside cultivation or on disturbed land is rare (OECD, 
2000). Establishment of feral soybean populations has never been observed in Europe. 
Soybean volunteers are rare throughout the world and do not effectively compete with the 
succeeding crop or primary colonisers (OECD, 2000). 
Soybean is a highly domesticated crop and generally unable to survive in the environment 
without management intervention (Lu, 2005). The soybean plant is not weedy in character. 
As for all domesticated crops, soybean has been selected against seed shattering to reduce 
yield losses during harvesting. Cultivated soybean seeds rarely display any dormancy 
characteristics and have poor seed survivability in soils (OECD, 2000). Due to low frost 
tolerance, susceptibility to plant pathogens, rotting and germination, the seeds will normally 
not survive during the winter (Owen, 2005). The soybean seeds need a minimum soil 
temperature of 10 °C to germinate and the seedlings are sensitive to low temperatures 
(OECD, 2000; Bramlage et al., 1978). Soybean is a quantitative short-day plant that needs 
short days for induction of flowering, and the growing season in Norway is too short for the 
soybean plant to reach full maturity. Potential soybean plants resulting from accidental 
release of viable seeds would therefore not be able to reproduce under Norwegian growing 
conditions.   
There is no reason to assume that expression of the introduced characteristics in soybean 
A5547-127 will increase the potential to establish feral populations. A series of field trials 
with soybean A5547-127 was conducted by the applicant at several locations in the USA in 
1996, 1997, 2006 and 2007 to compare the agronomic performance and field characteristics 
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of soybean A5547-127 with its comparators (see section 3.3).  With the exception of 
targeted responses to the presence of glufosinate herbicides, the agronomic and 
morphological field trial data did not show major changes in plant characteristics indicating 
altered fitness, persistence and invasiveness of soybean A5547-127 plants compared to its 
conventional counterpart.  
In addition to the data presented by the applicant, the VKM GMO Panel is not aware of any 
scientific reports indicative of increased establishment or spread of soybean A5547-127, or 
changes to its survivability (including over-wintering), persistence or invasive capacity. 
Because the general characteristics of soybean A5547-127 are unchanged, the herbicide 
tolerance is not likely to provide a selective advantage in Norway. The VKM GMO Panel is of 
the opinion that the likelihood of unintended environmental effects based on establishment 
and survival of soybean A5547-127 will not differ from that of conventional soybean 
varieties. 
5.2 Potential for gene transfer 
A prerequisite for any gene transfer is the availability of pathways for the transfer of genetic 
material, either through horisontal gene transfer of DNA, or vertical gene flow via pollen or 
seed dispersal. Transgenic DNA is also a component of a variety of food and feed products 
derived from soybean A5547-127. This means that micro-organisms in the digestive tract in 
humans and animals (both domesticated animals and other animals feeding on fresh or 
decaying plant material from the transgenic soybean) may be exposed to transgenic DNA. 
 Plant to micro-organisms gene transfer 5.2.1
Experimental studies have shown that gene transfer from transgenic plants to bacteria rarely 
occurs under natural conditions and that such transfer depends on the presence of DNA 
sequence similarity between the DNA of the transgenic plant and the DNA of the bacterial 
recipient (Nielsen et al. 2000; De Vries & Wackernagel, 2002, reviewed in EFSA, 2004, 
2009a; Bensasson et al., 2004; VKM, 2005). 
Based on established scientific knowledge of the barriers for gene transfer between 
unrelated species and the experimental research on horisontal transfer of genetic material 
from plants to microorganisms, there is today little evidence pointing to a likelihood of 
random transfer of the transgene present in soybean A5547-127 to unrelated species such 
as bacteria.   
It has, however, been pointed out that there are limitations in the methodology used in 
these experimental studies (Nielsen & Townsend, 2004). Experimental studies of limited 
scale should be interpreted with caution given the scale differences compared to commercial 
plant cultivation.  
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Experiments have been performed to study the stability and uptake of DNA from the 
intestinal tract in mice after M13 DNA was administered orally. The DNA introduced was 
detected in stool samples up to seven hours after feeding. Small amounts (<0.1%) could be 
traced in the blood vessels for a period of maximum 24 hours, and M13 DNA was found in 
the liver and spleen for up to 24 hours (Schubbert et al., 1994). Following oral intake, it has 
been shown that DNA from GM soybean is more stable in the intestine of persons with 
colostomy compared to a control group (Netherwood et al., 2004). No GM DNA was detected 
in the faeces from the control group. Rizzi et al. (2012) provides an extensive review of the 
fate of feed-derived DNA in the gastrointestinal system of mammals.  
In conclusion, the VKM GMO Panel considers it is unlikely that the introduced gene from 
soybean A5547-127 will transfer to and establish itself in the genome of microorganisms in 
the environment or in the intestinal tract of humans or animals. In the rare, but theoretically 
possible case of transfer of the pat gene from A5547-127 to soil bacteria, no novel property 
would be introduced into or expressed in the soil microbial communities, as these genes are 
already present in other bacteria in soil. Therefore, no positive selective advantage for the 
soil bacteria, which would not have been conferred by natural gene transfer between 
bacteria, is expected. 
 Plant to plant gene flow 5.2.2
The genus Glycine has two distinct subgenera; Glycine and Soya. The subgenus Glycine 
contains 16 perennial wild species, whilst cultivated soybean (G. max) and its wild and semi-
wild annual relatives, G. soja and G. gracilis are classified in the subgenus Soja (OECD 
2000). Wild soybean species are endemic to China, Korea, Japan, Taiwan and the former 
USSR, while these species have not been reported in Europe or in North America.  
Soybean is predominantly a self-pollinating species, propagated commercially by seed. The 
percentage of cross-pollinating is usually less than one percent (LU, 2005; OECD, 2000). The 
dispersal of pollen is limited because the anthers mature in the bud and directly pollinate the 
stigma of the same flower. Pollination and fertilisation are usually accomplished before the 
flower opens (Acquaah, 2012).  
Since there is no cultivation of soybean in Norway and the species has no sexually 
compatible wild relatives in Europe, accidental seed spillage during transportation and/or 
processing of soybean A5547-127 will not present a risk of spread of transgenes to organic 
or conventionally grown varieties, wild populations or closely related species in Norway.   
5.3 Interactions between the GM plant and target organisms 
Considering the intended uses of soybean A5547-127, excluding cultivation and the absence 
of target organisms, potential interactions of the GM plant with target organisms were not 
considered an issue by the VKM GMO Panel. 
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 5.4 Potential interactions between the GM plant and non-target 
organisms (NTOs) 
Considering the intended uses of soybean A5547-127, excluding cultivation, potential 
interactions of the GM soybean with non-target organisms were not considered an issue by 
the VKM GMO Panel. 
5.5 Potential interactions with the abiotic environment and 
biochemical cycles 
Considering the intended uses of soybean A5547-127, which exclude cultivation, and the low 
level of exposure to the environment, potential interactions of the GM plant with the abiotic 
environment and biogeochemical cycles were not considered an issue by the VKM GMO 
Panel.  
5.6 Conclusion 
Considering the intended uses of soybean A5547-127, excluding cultivation, the 
environmental risk assessment is concerned with accidental release into the environment of 
viable grains during transportation and processing, and indirect exposure to microorganisms 
in the gastrointestinal tract and soil/water, mainly via intestinal content and faeces from 
animals fed feeds containing soybean A5547-127.  
Soybean A5547-127 has no altered survival, multiplication or dissemination characteristics 
compared to conventional soybean, and there are no indications of an increased likelihood of 
spread to or establishment of feral soybean plants in the case of accidental release of seeds 
from soybean A5547-127 into the environment. Soybean is not cultivated in Norway, and 
there are no cross-compatible wild or weedy relatives of soybean in Europe. Plant to plant 
gene flow is therefore not considered to be an issue. Considering the intended use as food 
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 6 Post-market environmental 
monitoring 
Directive 2001/18/EC introduces an obligation for applicants to implement monitoring plans, 
in order to trace and identify any direct or indirect, immediate, delayed or unanticipated 
effects on human health or the environment of GMOs as or in products after they have been 
placed on the market. Monitoring plans should be designed according to Annex VII of the 
Directive. According to Annex VII, the objectives of an environmental monitoring plan are 1) 
to confirm that any assumption regarding the occurrence and impact of potential adverse 
effects of the GMO or its use in the environmental risk assessment (ERA) are correct, and (2) 
to identify the occurrence of adverse effects of the GMO or its use on human health or the 
environment which were not anticipated in the environmental risk assessment. 
Post-market environmental monitoring is composed of case-specific monitoring and general 
surveillance (EFSA 2011c). Case-specific monitoring is not obligatory, but may be required to 
verify assumptions and conclusions of the ERA, whereas general surveillance is mandatory, 
in order to take account for general or unspecific scientific uncertainty and any unanticipated 
adverse effects associated with the release and management of a GM plant. Due to different 
objectives between case-specific monitoring and general surveillance, their underlying 
concepts differ. Case-specific monitoring should enable the determination of whether and to 
what extent adverse effects anticipated in the environmental risk assessment occur during 
the commercial use of a GM plant, and thus to relate observed changes to specific risks. It is 
triggered by scientific uncertainty that was identified in the ERA. 
The objective of general surveillance is to identify unanticipated adverse effects of the GM 
plant or its use on human health and the environment that were not predicted or specifically 
identified during the ERA. In contrast to case-specific monitoring, the general status of the 
environment that is associated with the use of the GM plant is monitored without any 
preconceived hypothesis, in order to detect any possible effects that were not anticipated in 
the ERA, or that are long-term or cumulative.  
No specific environmental impact of genetically modified soybean A5547-127 was indicated 
by the environmental risk assessment and thus no case specific monitoring is required. The 
VKM GMO Panel is of the opinion that the monitoring plan provided by the applicant is in line 
with the intended uses of soybean A5547-127. 
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 7 Conclusions  
Molecular characterisation 
The applicant has provided sufficient analyses to characterise the DNA inserts, number of 
inserts, integration sites and flanking sequences in the soybean genome. The results show 
that one full length functional copy of the pat gene is present in the soybean A5547-127 
genome. Similarity searches in 2007 and 2009, with databases of known toxins and allergens 
did not indicate any potential production of harmful proteins or polypeptides caused by the 
genetic modification. Southern blot and segregation analyses show that the introduced gene 
elements are stably inherited and expressed over several generations, and consistent with 
the observed phenotypic characteristics of soybean A5547-127. The VKM GMO Panel 
concludes that the molecular characterisation of soybean A5547-127 does not indicate a 
safety concern. 
Comparative assessments 
The VKM GMO Panel has considered the available literature on compositional data and found 
that except for small intermittent variations, no biologically significant differences exist 
between soybean A5547-127 and its corresponding control A5547 in the analysis of seeds 
and processed food and feed commodities. Any differences observed were within the range 
of values reported for conventional soybean varietals in the literature. The few observed 
statistical differences between A5547-127 and A5547 are likely to reflect the natural 
variability of the analytes since they were within the range of values reported in the 
literature for conventional soybean varietals. The data presented do not show unintended 
effects as a result of the genetic modification.  
Based on current knowledge, the VKM GMO Panel concludes that with the exception of the 
introduced trait, soybean A5547-127 is compositionally, agronomically and morphologically 
equivalent to its conventional counterpart and other conventional soybean varieties.  
Food and feed risk assessment 
A 14-day repeated dose toxicity study with rats fed PAT protein, as well as a nutritional 
assessment trial with broilers fed diets containing soybean A5547-127 did not indicate any 
adverse effects. The PAT protein in A5547-127 does not show sequence resemblance to 
known toxins or IgE-dependent allergens, nor has it been reported to cause IgE-mediated 
allergic reactions.  
Based on current knowledge, the VKM GMO Panel concludes that soybean A5547-127 is 
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Environmental assessment 
Considering the intended uses of soybean A5547-127, excluding cultivation, the 
environmental risk assessment is concerned with accidental release into the environment of 
viable grains during transportation and processing, and indirect exposure to microorganisms 
in the gastrointestinal tract and soil/water, mainly via intestinal content and faeces from 
animals fed feeds containing soybean A5547-127. Soybean A5547-127 has no altered 
survival, multiplication or dissemination characteristics compared to conventional soybean, 
and there are no indications of an increased likelihood of spread to or establishment of feral 
soybean plants in the case of accidental release of seeds from soybean A5547-127 into the 
environment. Soybean is not cultivated in Norway, and there are no cross-compatible wild or 
weedy relatives of soybean in Europe. Plant to plant gene flow is therefore not considered to 
be an issue. Considering the intended use as food and feed, interactions with the biotic and 
abiotic environment are not considered to be an issue. 
Overall conclusion 
Based on current knowledge and considering the intended usage, the VKM GMO Panel 
concludes that soybean A5547-127 is as safe as its conventional counterpart and other 
commercial soybean varieties. With the exception of the introduced trait, soybean A5547-127 
is nutritionally, morphologically and agronomically equivalent to conventional soybean 
varieties.  
Likewise, the VKM GMO Panel concludes that soybean A5547-127 does not represent a 
discernible environmental risk in Norway. 
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 8 Data gaps 
Herbicide tolerant (HT) crops permit the use of broad-spectrum herbicides such as 
glyphosate, as an in-crop selective herbicide to control a wide range of broadleaf and grass 
weeds without sustaining crop injury. This weed management strategy enables post-
emergence spraying of established weeds and gives growers more flexibility to choose 
spraying times in comparison with the pre-emergence treatments of conventional crops. 
As the broad-spectrum herbicides are sprayed on the plant canopy and often takes place 
later in the growing season than is the case with selective herbicides associated with 
conventional crops, the residue and metabolite levels of herbicides in plants with tolerance to 
glyphosate could be higher compared to plants produced by conventional farming practices. 
There are however limited amounts of data available on herbicide residues in HT crops.     
More research is needed to elucidate whether the genetic modifications used to make a plant 
tolerant against certain herbicide(s) may influence the metabolism of this or other plant 
protection products, and whether possible changes in the spectrum of metabolites may 
result in altered toxicological properties.  
At present, the potential changes related to herbicide residues of genetically modified plants 
as a result of the application of plant protection products fall outside the remit of the 
Norwegian Scientific Committee for Food Safety.  
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Figure 1. Schematic overview of the newly created ORFs and genes in soybean event A5547-127 
(figure 1 in the BayerCropScience response to EFSA, 15 april 2009) 
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Table AI-1. Segregation data for individuals and rows of progeny of self-pollinated event A5547-127 
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 Appendix II 
Table AII-1. Summary of the field trials performed for compositional and agronomic comparative 
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Table AII-2. Components analysed in Raw Soybean Seeds and Products derived from Soybeans 
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Table AII-4. Mean values and standard deviations for the content of proximates in seeds over all 
sites, listed separately for the three treatments: A: nontransgenic A5547, B: transgenic A 5547-127 
not sprayed, C: transgenic A 5547-127 sprayed with glufosinate. Standard values from the literature is 




Table AII-5. Summary of the by site analysis of the proximate data of seeds for the A: nontransgenic 
A5547, B: transgenic A 5547-127 not sprayed, C: transgenic A 5547-127 sprayed with glufosinate 
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Table AII-6. Mean levels and standard deviations for Amino Acids in Seeds of A: nontransgenic 
A5547, B: transgenic A 5547-127 not sprayed, C: transgenic A 5547-127 sprayed with glufosinate, 
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Table AII-8. Mean levels and standard deviations for Fatty Acids in Seeds of A: nontransgenic 
A5547, B: transgenic A 5547-127 not sprayed, C: transgenic A 5547-127 sprayed with glufosinate, 
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Table AII-10. Mean levels and standard deviations for minerals and vitamins in Seeds of A: 
nontransgenic A5547, B: transgenic A 5547-127 not sprayed, C: transgenic A 5547-127 sprayed with 
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Table AII-12.  Mean levels and standard deviations over all sites for Anti-nutrients in Seeds of A: 
nontransgenic A5547, B: transgenic A 5547-127 not sprayed, C: transgenic A 5547-127 sprayed with 






Table AII-13. Summary of the by site analysis of Anti-nutrients in Seeds of A: nontransgenic A5547, 
B: transgenic A 5547-127 not sprayed, C: transgenic A 5547-127 sprayed with glufosinate (Technical 
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AII-14. Mean levels and standard deviations for Isoflavones in Seeds of A: nontransgenic A5547, B: 
transgenic A 5547-127 not sprayed, C: transgenic A 5547-127 sprayed with glufosinate, over all sites, 
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Table AII-16. Agronomic and morphological characteristics evaluated in GM soybean 
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Table AII-17. Results of the by-site t-test for agronomic and morphological characteristics.  
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 Appendix III 
 
Soy products 
By Dagrunn Engeset and Inger Therese Lillegaard 
There are different soy-products on the market: milk replacement products (milk, sour 
cream, yoghurt, and cheeses), meat replacement products (soy granules to mix in water to 
make “minced meat “, and ready made products like sausages, burgers, nuggets, and 
schnitzels), desserts (vanilla and chocolate puddings, ice creams, cheese cakes), soy flour, 
soy flakes, soy beans, soy fat/oils, and –sauce. There are also soy proteins in several diet 
bars and diet products, and in a few canned meat products. Many chocolates and biscuits 
contain soy lecithin. 
In this project, two different menus have been created; one full day week menu for a person 
with milk allergy and one full day week menu for a vegan (see below). The goal was to 
examine how much soy protein a person can consume, realistically, by replacing meat and 
milk products with soy-products. 
Reason for the choice of menus 
The milk allergy menu   
Milk allergy or intolerance are relatively common conditions. Persons with such conditions 
will have to look for alternatives to milk and milk products, and soy products will be a natural 
choice for many of them. There are other milk replacement products on the market, but in 
this scenario we envision a person who prefers soy over other products. This menu is also 
relevant for persons who for various reasons do not wish to use milk products and therefore 
replaces them with soy products. 
 
The vegan menu  
A vegan does not eat any products of animal origin; meat, fish, milk products, or eggs. In 
this scenario we envision a vegan who has previously eaten normal food and wishes to 
replace meat products with meat replacement products like soy sausages and -burgers in 
addition to replacing milk products. In both menus, all milk products are replaced with soy 
products: soy milk substitute for drinking, in waffles, in porridge and on breakfast cereals, in 
smoothies, and in cheese sauces. 
Coffee milk is substituted with soy cream in coffee or tea. Cheeses are replaced by different 
soy cheeses and/or tofu on bread, and in dishes like lasagne and pizza. Tofu is also used in 
cheese cake, smoothies, and in salads. 
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Soy yoghurt, ice cream, cream, and sour cream replace ordinary yoghurt, ice cream, cream, 
and sour cream. In the vegan menu, meat products are replaced by meat substitutes of soy 
and of tofu in wraps and in lasagne. 
The menus are made with an estimated energy requirement of 10 MJ/day. We assume that 
in pure soy products (e.g. soy milk) all the protein comes from soy. In mixed products, the 
amount of soy protein is estimated based on how much soy was stated in the table of 
content printed on the food label.  
7 day vegan menu, high preference for soy products  
(envision a person who has previously eaten meat and is looking for meat substitutes like 
soy burgers and sausages)  
 
Monday: 
Breakfast: Cereals with nuts and soy milk, orange juice, coffee/tea with soy cream 
Lunch: course bread with soy cheese, cucumber and tomato, bell pepper, peanut butter, soy 
milk, coffee/tea with soy cream 
Snack:  banana, walnuts   
Dinner: soy burger, burger bread, tomato, lettuce, pickles, raw onion, soy cheese, soy 
chocolate dessert, water  
Supper:  mixed salad with tofu, vinaigrette dressing and pita bread, tea  
 
Tuesday:  
Breakfast: cereals with nuts and soy milk, orange juice, coffee with soy cream (like Monday) 
Lunch: tofu wrap (tortilla with tofu + vegetables), soy milk, coffee with soy cream  
Snack: apple, soy ice cream  
Dinner: Steamed vegetables with cheese sauce (made of soy milk and soy cheese), water, 
soy yoghurt with nuts and raisins  
Supper: oat porridge with raisins and soy milk  
 
Wednesday: 
Breakfast: Soy smoothie (tofu, soy milk, banana, strawberries) 
Lunch: tofu wrap, soy milk, coffee (like Tuesday) 
Snack: soy yoghurt  
Dinner: Soy sausages , mixed salad with tofu, rice, water, vanilla soy dessert  
Supper:  course bread with peanut butter, soy cheese and vegetables, soy milk and coffee 
(like lunch Monday) 
 
Thursday: 
Breakfast: cereals with nuts and soy milk, orange juice, coffee with soy milk 
Lunch: bread lunch like Monday 
Snack: Soy smoothie (like breakfast Wednesday) 
Dinner: Vegetable soup, course rye bread with milk free margarine, water 
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Breakfast: bread breakfast (like Thursday supper) 
Lunch:  mixed salad with tofu (like Monday supper) 
Snack: Soy waffle with jam and soy sour cream (waffles of soy milk, peanut butter, soy oil, 
buck wheat, corn starch, corn flour), soy chocolate milk (hot) with whipped cream (soy 
whipping spray cream) 
Dinner: Spinach and tofu lasagne (lasagne plates, spinach, tofu, soy milk, soy cheese, 
tomato sauce) with mixed salad and white bread, wine and water 
Supper:  fruit salad 
 
Saturday: 
Breakfast:  Soy smoothie (as previous) 
Lunch: Soy waffle (like Friday snack) 
Snack: Milk chocolate without milk, cashew nuts, raspberries 
Dinner: Vegetarian bean casserole, pita bread, wine, water, soy chocolate dessert  
Supper: Vegan pizza (marguerita with soy cheese), beer, potato chips 
 
Sunday: 
Breakfast:  soy sausages, chapatti, onion, pickles, tomato juice, tea 
Lunch: tofu wrap (like lunch Tuesday) 
Snack: fruit salad 
Dinner: Vegan meatballs (chickpeas, tofu, water, rolled oats, wheat flour) in tomato sauce, 
spaghetti, mixed salad, soda, soy chocolate dessert 
Supper: vegan cheesecake with raspberries (cheese cream topping: soy cream cheese, tofu, 
sugar, lemon), coffee 
7 day menu, milk allergy - replaces milk products with soy products. 
Monday:  
Breakfast: Oat porridge (like vegan) 
Lunch: Bread with salami and soy cheese, tomato/cucumber/bell pepper, orange juice,coffee 
Snack: Banana, walnuts 
Dinner: Sausages without milk, mashed potatoes with soy milk, mixed salad, water 




Breakfast: Bread breakfast (like Monday lunch) 
Lunch: Bread lunch (like Monday supper) 
Snack:  Smoothie (like vegan) 
Dinner: Vegetable soup (like vegan Thursday) 
 
VKM Report 2015: 08  93 
 
Supper: omelette with bread, soy milk, tea 
 
Wednesday: 
Breakfast: Weetabix with soy milk 
Lunch: Bread lunch (like Monday supper) 
Snack: Banana and nuts 
Dinner: Meat balls, mushy peas, potatoes, carrots, sauce, lingonberry jam, water  
Supper: Oat porridge (like vegan) 
 
Thursday: 
Breakfast: Smoothie (soy milk, strawberries, banana, apple juice) 
Lunch: Bread lunch (like Monday supper) 
Snack: Soy yoghurt with nuts, grapes  
Dinner: Fish gratin made with soy milk, carrots, bacon, water, soy chocolate dessert 
Supper: oat porridge (like vegan) 
 
Friday: 
Breakfast: Corn flakes with soy milk, coffee, orange juice 
Lunch: Tomato soup with macaroni (without milk), white bread, water 
Snack: Milk chocolate without milk, cashew nuts, raspberries 
Dinner: Lasagne (cheese sauce of soy milk and soy cheese), mixed salad, pita bread, wine, 
water, soy ice cream 
Supper: Pizza with soy cheese, beer, potato chips 
 
Saturday: 
Breakfast: Egg and bacon, bread, orange juice, coffee 
Lunch: Mixed salad with chicken and tofu, pita bread, water 
Snack: Smoothie (like Thursday breakfast) 
Dinner: Rice porridge made with soy milk, mutton ham, lemonade 
Supper: Taco with soy sour cream and soy cheese, beer 
 
Sunday: 
Breakfast: Omelette with soy cheese, bread, cucumber/bell pepper, orange juice, tea 
Lunch: waffle with soy milk (ordinary waffle with egg where soy milk replaces milk) , jam, 
soy sour cream, coffee with soy cream and sugar 
Snack: Milk free milk chocolate, nuts, fruit 
Dinner: Salmon with potato, soy sour cream, cucumber, carrots, water, fruit salad 
Supper: Vegan cheesecake with raspberries, coffee 
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 Appendix IV 
 
A rather extensive safety testing programme has been conducted on soybean A5547-127 
within the Russian Federation and summarised in “Tutelyan VA (2013) Genetically Modified 
Food Sources. Safety Assessment and Control. Amsterdam: Academic Press, Elsevier. DOI: 
10.1016/B978-0-12-405878-1.00009-4”. The research and testing is claimed compliant with 
national requirements (MY 2.3.2.2306-07 “Medico-biological safety assessment of 
genetically-engineered and modified organisms of plant origin”). The content of these 
requirements and the exact design of the respective studies have been difficult to assess for 
the VKM GMO panel. A brief summary of the testing is thus presented below. 
Toxicological assessment of the whole GM food/feed 
Potential genotoxicity of soybean A5547-127 
The potential genotoxicity of soybean A5547-127 was investigated in an in vivo experiment 
in mice (Tutelyan, 2013). The study was conducted in accordance with the requirements of 
the Ministry of Health of the Russian Federation authorized for risk and safety assessment of 
food derived from GM sources (MUK 2.3.2.970-00, 2008). The genotoxicity studies were 
carried out on male C57Bl/6 and female CBA mice sensitive to mutagenesis. For 45 days, the 
mice weighing 20-25 g were fed diet with protein concentrate from soybean A5547-127 (test 
group n=15 mice) or its conventional counterpart (control group n=12 mice) with daily feed 
intake of 1.5 g/day/animal. These studies examined chromosomal aberrations in the cells of 
bone marrow and the dominant lethal mutations in the gametes of control and test mice. 
The cytogenetic analysis was carried out by metaphasic method (MUK 2.3.2.970-00, 2000). 
The mice of both groups were sacrificed 24 h after the last feeding. Two hours prior to 
termination of the experiment, the mice were intraperitoneally injected with colchicine to 
accumulate cells at the metaphasic stage of nuclear division. Bone marrow was isolated from 
both femoral bones. A total of 70–80 cells were taken for analysis from each mouse from the 
group of 2-month old male C57Bl/6 mice weighing 20–25 g. Genetic alterations in gametes 
were examined by assessing dominant lethal mutations.  
After the 45-day feeding period, the C57Bl/6 test (n=15) and  control (n=12) male mice 
were caged with virgin CBA female mice in a ratio of 1:2. The mating period of 3 weeks was 
sufficient to assess the effect of soybean diet on sex cells (spermatids and spermatozoa) 
during the postmeiotic period. Pregnant females were isolated and sacrificed on gestation 
days 15–17 by cervical dislocation. Numbers of corpus lutea and live and dead embryos were 
recorded. These data were used to calculate mutagenic parameters: pre-implantation, post-
implantation, and inducible mortality. 
Among various structural chromosomal abnormalities in animals of both groups, there were 
single segments, one circular chromosome (in a test mouse), and gaps.  The number of cells 
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with such chromosomal abnormalities did not significantly differ in parental (F0) and first 
generation (F1) mice fed soy protein concentrate from A5547-127 or conventional 
counterpart soybeans.  
To examine the dominant lethal mutations, 64 test and 56 control females were dissected to 
analyze embryos and corpus lutea. In the test group 393 embryous and 425 corpus lutea 
were analysed. The corresponding values in control mice were 350 embryos and 376 corpus 
lutea. The pre-implantation mortality was similar in the control and test groups. 
At the stages of early and late spermatids or mature spermatozoa, the post-implantation 
embryonic mortality (the most reliable index of mutagenic activity of an examined 
substance) varied within equal range in the test and control groups. The induced mortality at 
these stages was in the range 0−1%, indicating the absence of mutagenic effect of 
transgenic soybean line A5547-127 on spermiogenesis in mice. 
The Russian investigators concluded that glufosinate-tolerant soybean line A5547-127 
produced no mutagenic effect in the described experiments.  
Subchronic feeding studies in rats w ith soy protein concentrate derived from 
soybean A5547-127 
A feeding study over 180 days with soy protein concentrate was conducted on male Wistar 
rats. Biochemical, hematological, and morphological parameters were monitored in 
accordance with the requirements of the Ministry of Health of the Russian Federation 
authorized for risk and safety assessment of food derived from GM sources (Tutelyan, 2013). 
Male Wistar rats (n = 60) with a body weight of 85–95 g were randomised into two groups. 
The test rats were provided daily with protein concentrate derived from the transgenic 
soybean line A5547-127. The control rats were provided with the same amount of protein 
concentrate prepared from the conventional counterpart. The amount of the protein 
concentrate in the semi-synthetic diets was 22.5 g per 100 g diet. Samples were collected on 
days 30 and 180 of the experiment.  
During the entire length of the experiment, the general condition of the rats was similar in 
the control and test groups. No mortality was observed in either group. The absolute and 
relative weights and visual inspection of internal organs did not reveal any differences 
between the two groups. The histological assessments of internal organs (liver, kidneys, 
lung, spleen, small intestine, and testicle) revealed no differences between the control and 
test groups. The content of total protein, glucose, activity of alkaline phosphatase, alanine 
aminotransferase, and aspartate aminotransferase in blood serum, pH and the relative 
density of urine, urinary concentration of creatinine and its urinary excretion did not 
significantly differ between control and test rats at day 30 and 180. Hematological assays 
showed that feeding rats with protein concentrate derived from transgenic soybean line 
A5547-127 did not induce significant changes in concentration of hemoglobin, hematocrit, 
total erythrocyte count, MCH, MCHC, MCV, total leukocyte count, absolute and relative count 
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of eosinophils, neutrophils, and lymphocytes relative to the control values obtained at  30 
and 180 days. 
Assessment of allergenicity of proteins derived from the GM plant 
Assessment of possible sensitivisation of A5547-127 on the immune response to endogenous 
metabolic products was carried out by testing sensitivity to histamine in mice (Tutelyan 
2013). For 21 days, the control and test mice were fed diets with protein concentrate derived 
from conventional and transgenic soybean. Then the mice of both groups were injected 
intraperitoneally with 2.5 mg histamine hydrochloride dissolved in 0.5 mL physiological saline 
solution. Twenty-four hours post-injection, all mice were alive. The lifetime of the mice in the 
test group was somewhat longer than that of the control mice: the test mice infected with 
105 or 104 microbial cells lived 4.2 and 6.2 days as compared with 1.2 and 2.2 days for the 
control mice. The smaller doses did not reveal any difference in the lifetime of mice in either 
groups. The values of LD50 were 256 and 175 bacterial cells per mouse in the test and 
control groups, respectively. The authors concluded that soybean A5547-127 does not 
contain any sensitising ingredient for mice.  
 Studies on Immunotoxicity  9.1.1
Potential effect on humoral component of immune system 
Level of hemagglutination after injecting sheep erythrocytes 
The immunomodulating effect of GM soybean on the humoral component of the immune 
system was examined by determining the level of hemagglutination after injecting sheep 
erythrocytes (SE) to mouse lines C57Bl/6 (low sensitivity to SE) and CBA (high sensitivity to 
SE) (Tutelyan, 2013). Soybean protein concentrate was fed to mice for 21 days. The control 
and test mice were fed a diet with conventional and transgenic soybean line A5547-127, 
respectively. On Day 21 the mice of both groups were intraperitoneally injected with 0.5 mL 
sheep erythrocytes (SE) (10 million cells). Blood was subsequently drawn on day 7, 14, and 
21. Blood serum was titrated for reaction of hemagglutination by routine method. All mice 
demonstrated the presence of antibodies against SE. For both CBA mice fed diet with soy 
protein concentrate derived from transgenic soybean line A5547-127 and mice fed protein 
concentrate from conventional soybean, the antibody appeared on Day 14 post-
immunization at the titer of 1:16. According to the Russian investigators the synthesis rate of 
the antibodies raised against SE were similar in C57Bl/6 and CBA mice lines fed diet with soy 
protein concentrate derived from transgenic soybean and in mice of the same lines fed on 
conventional soy protein concentrate. 
 
Hypersensitivity reaction to sheep erythrocytes 
The possible immunomodulating effect of transgenic soybean was assessed with delayed 
hypersensitivity reaction to sheep erythrocytes (SE) (Tutelyan, 2013). C57Bl/6 and CBA mice 
were used in this test. Each strain was divided in three groups, one group was fed soybean 
protein concentrate from A5547-127, one was fed conventional soybean protein concentrate 
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and one was fed without soybean (control group). The soybean protein concentrate was 
added to the diet for 21 days; thereafter, sheep erythrocytes (SE) was injected 
subcutaneously (1 million cells per mouse). On post-injection Day 5, SE (0.02 mL, 109 cells) 
were injected into the finger-pad of the right hindleg of control and test mice. The left 
hindleg was injected with 0.02 mL physiological saline solution. Local inflammatory reaction 
was assessed 18 h after the injections by comparison of the weights of both injected paws. 
The studies demonstrated the absence of any significant differences in the parameters of 
local inflammatory reaction in mice of either examined lines fed diet with soy protein 
concentrate derived either from transgenic soybean line A5547-127 or from conventional 
soybean. However, test C57Bl/6 mice fed diet with soy protein concentrate derived from 
transgenic soybean line A5547-127 demonstrated a small but statistically significant (p < 
0.05) elevation of this parameter in comparison with the control group fed diet with 
conventional soy protein concentrate, but no significant differences were observed when 
compared with the control mice maintained on the standard vivarium diet. 
These results showed that soybean A5547-127 did not contain elevated sensitising 
components compared to the control soybean.  
 
 Potential Effect on Cellular Component of Immune System 
Effect of soybean A5547-127 on susceptibility to Salmonella typhimurium 
Effect of soybean A5547-127 on susceptibility to Salmonella typhimurium was investigated in 
mice (Tutelyan, 2013). Mice fed diets supplemented with protein concentrate derived from 
conventional or transgenic soybean for three weeks were subsequently injected 
intraperitoneally with various doses of Salmonella typhimurium strain 415. The injected 
doses ranged from 100 to 105 microbial cells per mouse and varied on a 10-fold basis. The 
post-injection observation period was 18 days, and all mice were dead prior to day 18. The 
lifetime of the mice in the control group was somewhat longer than that of the test mice: the 
test mice lived 11.3 and the control lived 14.7 days. The lower doses did not reveal any 
difference in the lifetime of mice in both groups. These data showed that Salmonella 
typhimurium produced typical infection both in control mice fed diet with conventional 
soybean protein concentrate and in the test mice fed diet with transgenic protein 
concentrate. According to the difference in the time to death, the control group survived 
longer than the test mice, although the differences in LD50 values  (LD50 control and test 
was 72 and 69, respectively) remained within the experimental error. Thus, introduction of 
protein concentrate derived from transgenic soybean line A5547-127 into mouse diet 
produced no effect on the humoral and cellular components of the immune system, did not 
sensitize the mouse organism, and did not disturb the natural resistance against typical 
infection such as murine typhus. Taken together, these data support the conclusion that 
transgenic soybean line A5547-127 has no immunomodulating properties. 
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Assessment of systemic anaphylaxis 
The potential impact of soybean A5547-127 on systemic anaphylaxis was investigated in rats 
(Tutelyan, 2013). The model employed was according to standard protocols as described in 
the Russian Methodical Guidelines (MUK 2.3.2.970-00, 2000). The study was performed on 
male Wistar rats (n = 47) weighing 140 ± 10 g. After a 7-day adaptation period to standard 
vivarium diet, the rats were fed a diet supplemented with protein concentrate (3.1 g protein 
concentrate/ 100 g diet) derived from conventional soybean (control group) or from soybean 
line A5547-127 for 28 days. During the entire experiment the rats of both groups grew 
normally. 
On experimental days 1, 3 and 5, the rats were sensitized intraperitoneally with 100 μg 
ovalbumin from hens’ eggs (OVA). On Day 21, another portion of 10 μg OVA was 
administered under the same conditions to induce the secondary immune response. After 
termination of feeding animals with the diets on experimental Day 29, blood (0.2 mL) was 
drawn from the tail vein in order to assess the antibody response. Then a booster dose of 
OVA (30 mg/kg in 0.5 mL isotonic apyrogenic 0.15 M NaCl saline) was injected intravenously. 
During the following 24 h, the development of any symptoms of active anaphylactic shock 
were evaluated by observation. Severity of anaphylactic shock was scored as follows: +(1), 
shiver, chill, dyspnea; ++(2), asthenia, ataxia, peripheral cyanosis; +++(3), convulsions, 
paralysis; ++++(4) fatal outcome. The anaphylactic index (AI) was calculated according to 
the Russian Methodical Guidelines (MUK 2.3.2.970-00, 2000) as the mean of anaphylactic 
severity scores in a group at 24 h after injection of the booster dose. Intensity of humoral 
immune response was assessed according to concentration of circulating specific 
immunoglobulin antibodies (the sum of IgG1 and IgG4 fractions) by the method of indirect 
solid-phase enzyme-linked immunosorbent assay (standard ELISA) on polystyrene. Results 
showed that rats fed diets with protein concentrate derived from line A5547-127 displayed a 
humoral immune response that was significantly lower in intensity compared to control rats. 
There was only an insignificant increase of anaphylactic reaction and mortality in the A5547-
127 group.  The degree of sensitization by ovalbumin in these rats did not increase 
compared with the rats fed diet with protein concentrate derived from conventional soybean. 
It was concluded from the study that the protein concentrate prepared from transgenic 
soybean line A5547-127 did not elevate allergic reactivity and sensitization towards the 
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